Hospital, Headley Way, Oxford, 0X3 9DU, United Kingdom. Patients with advanced kidney failure complain of early fatiguability that may be related to anaemia or hyperphosphataemia. The extracellular concentration of inorganic phosphate ([Pi]0) influences intracellular [Pi] ([Pi]j and [Pi]1 may modify ATP production by altering the phosphorylation potential (P.P. = [ATP}/{[ADP] X [Pi]}) or otherwise influencing mitochondrial function. Using 31P magnetic resonance spectroscopy, we studied skeletal muscle to determine the effects of elevated [Pi]0 on intracellular bioenergetics. 18 non-dialysed patients with chronic renal impairment were studied. The calf muscle was positioned over a surface coil within a superconducting whole body magnet. Spectra were collected at rest, during incremental plantar flexion and recovery, allowing calculation of intracellular pH and [Pi], [phosphocreatine] (PCr), [ATP], [ADP] and the maximum rate of mitochondrial ATP synthesis (Qmax). Results were compared with age-matched control subjects. Omax is known to be a sensitive indicator of mitochondrial dysfunction. [Pi], was increased in the patient group (Pi/ATP = 0.49 cf 0.38 in controls) and the [Pi]1 increase was correlated with the [Pij0 (P < 0.01). In all patients, [ADP} adapted to the increase in [Pi]1 and hence the P.P. remained constant throughout range of [Pu1. The constant P.P. suggests no change in the control for oxidative phosphoiylation in these uraemic patients. Since metabolism in skeletal muscle at rest is purely aerobic, the constancy of the PP. implies that PP. is more important than either [ADP] or [Pi]1 in the control of oxidative phosphorylation. Qmax remained constant (35 mM/mm) throughout a range of [Pi],, plasma [creatinine] and [Hb] and was similar to controls (32 mM/mm). Constancy of PP. and Omax over a similar range of [Pi], was seen in dialysed patients but, unlike undialysed patients, there were reductions in Omax and P.P. compared to controls. This suggests that control of ATP synthesis was not affected by changes in [Pij1 and that the institution of dialysis caused metabolic abnormalities in muscle nonexistent in the presence of advanced renal failure prior to dialysis. Long-term follow-up of patients with IgA nephropathy: The leading cause of glomerulonephritis in New Zealand. R.
within the first few years of follow-up. IgA nephropathy has a better outcome than earlier thought. These findings should prove of value in giving an individual patient a fairly precise prognosis at presentation.
Protein restriction in renal disease: Compliance and consequences. C.A. Pollock*, L.S. Ibels, R.J. Caterson, D.A. Waugh, IF. Mahony, Department of Renal Medicine, Royal North Shore Hospital, St. Leonards, NSW, 2065. Although restriction of dietary protein intake (DPI) is regarded as useful in retarding the progression of renal disease, recent evidence suggests this effect may not be as significant as originally supposed and may result in poor nutritional reserve when end stage renal failure is reached. 680 patients (aged 7-88 years) underwent 24 hour urine collections and the DPI was assessed from urea kinetic modelling. 526 patients had a normal serum creatinine, and of these 360 patients had no dietary restrictions. 166 patients were advised to follow a low DPI. 154 patients had increased serum creatinine of which 105 patients had received advice regarding restricted DPI. 7 patients were assessed before and after commencement of dialysis. Patients with a normal serum creatinine who had no dietary restriction had a significantly higher DPI than those advised in protein restriction (0.79 0.1 vs. 0.72 0.1 g/kg/day (mean sEM); P < 0.0001). However, in patients with abnormal renal function, dietary protein intake was similar irrespective of dietary advice (0.73 0.03 vs. 0.69 0.02 g/kg/day; P = 0.28). A lower DPI correlated with renal dysfunction independent of dietary advice (P < 0.0001). In the overall population a low DPI was associated with a lower BMI (24.5 0.3 vs. 25.5 0.2; P < 0.005), a lower serum albumin (43.8 0.2 vs. 44.7 0.2; P < 0.005), and inverse correlations were observed between DPI and age (P < 0.0001), blood glucose (P < 0.002), serum cholesterol (P < 0.002) and triglycerides (P < 0.0001). However, a disproportionate adverse effect on blood glucose and lipids, and serum albumin were not observed in the population with impaired renal function. Patients who reached end stage renal failure had no significant alteration in DPI within a month of commencement of dialysis (P = 0.86). The results of the study show that the DPI of the community is lower than expected, but compliance with dietary advice is evident. A low DPI in renal impairment occurs independently of dietary advice. Despite evidence that a proportionately higher carbohydrate intake may have adverse effects on the overall nutritional profile, this is not more common in patients with impaired renal function.
Adaptation to a high protein diet following instigation of dialysis is unsuccessful in the short term.
Cardiovascular risk factors are present in children and young adults with renal disease. L.M Johnstone*J, CL. Jones', L.E. Grigg2, T. Billing-ton3, J.L. Wilkinson4, R.G. Walker"5, HR. Powell', Departments of Nephrology', Cardiology", Royal Children's Hospital, Parkville Vic., 3052, Departments of Nephrology3 and Cardiology2, Royal Melbourne Hospital, Parkville, Vic., 3050, Department of Chemical Pathology5, St. Vincents Hospital, Fitzroy, Vie., 3065. Cardiovascular disease is a major cause of morbidity and mortality in adults with renal disease. Children with end stage renal failure are now being treated successfully with renal replacement therapies, and with long term survival may also be at increased risk of cardiovascular disease. To evaluate the prevalence of abnormalities in risk factors for cardiovascular disease a cross-sectional study was undertaken in a group of children and young adults with renal impairment or receiving renal replacement therapy. One hundred and thirty-three subjects were enrolled (60 controls, 33 patients with renal impairment (CRF), 10 patients requiring peritoneal dialysis (CAPD) and 30 patients post renal transplantation (TX). Parameters studied included echocardiograph with calculation of left ventricular mass (LVM) and serum lipid (total cholesterol, triglyceride, VLDL-, LDL-and HDL-cholesterols) and lipoprotein (apolipoproteins Al and B, lipoprotein (a)) concentrations. Serum cholesterol was increased in all groups with renal disease, (controls: 4.6 mmol/l (2.9-7.6), CRF: 5.3 mmol/l (3.2_9.l)**, CAPD: 6.1 mmolIl (3.4-8.2)**, TX: 5.2 mmolll (3.l_8.1)**); as was VLDL-cholesterol (controls: 0.5 mmol/l (0.2-1.3), CRF: 0.9 mmol/l (0.3...2.0)***, CAPD: 1.2 mmol/l (0.416)***, TX: 0.7 mmol/l (0.0_1.5)**). LDL-cholesterol was increased in CRF and TX subjects (controls: 2.6 mmol/l (1.3-5.5), CRF: 3.3 mmol/l (1.l_.6.6)***, TX: 3.1 mmol/l (1.5_4.8)**). HDL cholesterol was decreased in the CRF and CAPD groups (controls: 1.44 mmolll (1.0-3.1), CRF: 1.26 mmol/l (0.44_2.42)**, CAPD: 1.07 mmol/l (0.62l.28)***). LVM was indexed for height and found to be significantly increased in CAPD subjects (controls: 51.8 g/m (23.1-119.8), CAPD: 80.2 g/m (44.5-100.9)*) and in TX subjects compared to age and sex matched controls (controls 70.2 g/m (25.9-119.8), TX: 97.8 g/m (51.2_182.l)**). These results showed that children and young adults with renal disease have abnormal serum lipids with an atherogenic profile, and have an increased LVM when receiving renal replacement therapy. Thus, children with renal disease would appear to be at greater risk for premature cardiovascular disease. Results expressed as median (range). * P < 0.05, ' P < 0.01, ***p < 0.001.
Comparison of simultaneous renal clearances of true endogenous creatinine and subcutaneously administered iothalamate in man. Carol Pollock*, A.Z. Gyoiy, Therese Hawkins, Margaret Ross and Lloyd Ibels, Departments of Medicine, Sydney University and Renal Medicine, Royal North Shore Hospital, St. Leonards, Australia 2065. Accurate measurement of GFR in clinical practice is still problematic. Endogenous creatinine clearance is the logical method but has suffered from poor reproducibility and accuracy. In 71 (38 females) patients with various renal diseases we compared simultaneously measured '25lothalamate (lOT) and true endogenous creatinine clearances (TCrC1) over two short collections periods of 1 and 2 hrs. True endogenous creatinine was measured by the Jaffe adsorption method. Range of lOT was 5-141 mI/mm. Reproducibility of the JOT method was 18.5% and that of the TCrCI 12.2% as obtained from the two collection periods. Fig. 1 shows the correlation for the whole group, while Fig. 2 for those with lOT less than 30 mI/mm. The slope of the regression was not significantly different from 1 (95% confidence interval (ci) = 0.964-1.155) for the whole group, nor in any subgroup chosen. The intercept at 12.6 mI/mm (ci = 5.0-20.2) indicates that there is some creatinine secretion, but that this a constant percentage of TCrCI (unit slope). The probable reason why clearance of creatinine, using methods other than those giving true creatinine values give such widely vatying results, is because of variable contribution of other chromogens, and because both serum and urine creatinine change significantly with time if not refrigerated (long collection periods). It is concluded that TCrCI obtained during short collection periods is an excellent, reproducible, accurate and convenient measure of GFR.
Subureteric Polytef injection in the management of vesicoureteric reflux in children. PA. Dewan, D. W. Goh*, Urology Unit, Women's & Children's Hospital, Adelaide, SA 5006. Subureteric Polytef injection is one of the alternatives now available for the management of vesicoureteric reflux in children. The results of the treatment by one surgeon, over a two year period, were studied prospectively in 47 children (60 refluxing units). Following a single injection, reflux was abolished in 49 (82%) ureters and of the 11 failures, 10 ureters showed a reduction of the grade of reflux while one remained unchanged. A repeat injection was performed in nine of these ureters with success in five, persistence in two, and two children are awaiting a follow-up cystogram. The conservative success, with the addition of a second injection, was 90% (54/60). Of the four with unresolved refiux, two have low grade reflux and are free of infection, and two have had a ureteric reimplant, one of which was after a single injection, at the request of the parents. There were no instances of ureteric obstruction. These results show a viable, minimally invasive alternative to open ureteric reimplantation in the management of vesicoureteric reflux in children.
Oral trimethoprinl-sulphamethoxazole (TM-SMX) vs. inhaled pentamidine (P) for prevention of pneumocystis pneumonia (PCP) after renal transplantation. E. Pedagogos*, K Nicholls, J. Wilson, K Walker, G.
Becker, Depts. Nephrology and Respirato,y Medicine, RMH. 61 patients were randomised to receive prophaxis against PCP with either TM-SMX 800/160 mg B.D. (N = 32) or inhalational P 150 mg once a fortnight, commencing 14-days after transplantation and continuing for 6 months. All patients were treated with triple immunosuppression (prednisolone, azathioprine (AZA) and cyclosporin A). 49 patients (26TM-SMX, 23P) completed the study. No cases of PCP were seen. 5 patients died (3TM-SMX, 2P) of non-respiratory causes, 2 further patients (1 in each group) underwent graft nephrectomy for rejection, and 6 patients (2TM-SMX, 4P) were withdrawn. Data was analysed according to intention to treat. The dose of TM-SMX was halved if the serum creatinine level increased >02 mmol/L (N = 12). Both treatment modalities were well tolerated. Cough was common with P, but was controlled by slowing the rate of the inhalation. Renal and respiratory function tests done before treatment, and at 6 months, were not different in the 2 patient groups.
White cell counts (WCCs) were not significantly different between groups at any time, but the tolerated AZA doses (decreased from 2 mg/kg/day if WCC <4000/dL) were significantly lower in the P group (median daily doses at 1 month 125 mg TM-SMX, 100 mg P NS: 3 months 141 mg TM-SMX, 75 mg P < 0.05; 6 months 117 mg TM-SMX, 61 mg P < 0.05. This suggests that P may aggravate bone marrow depression due to AZA (Mann-Whitney U). Our patient numbers are too small to exclude small difference in efficacy between the 2 treatments. We conclude that either TM-SMX or P provides a well-tolerated option for PCP prevention, that the required dose of TM-SMX is probably only 400/80 mg B.D. and that TM-SMX is at least as good as that of P.
Deoxyspergualin inhibits local macrophage proliferation in rat renal allograft rejection. P.G. Ken*, D.J. Nikolic-Paterson, KY. Lan, S. Rainone, G. Tesch, and R. C. Atkins, Dept. of Nephrology, Monash Medical Centre, Clayton Vic. 3168 Australia. Deoxyspergualin (DSP) is a potent immunosuppressive drug which can prevent allograft rejection. Although there is good evidence that DSP can inhibit T and B lymphocyte responses, the effect of the drug upon monocyte function is controversial. In the current study, substantial local proliferation of inflammatory macrophages within acutely rejecting rat renal allografts (41.6 5.5% of ED1+ cells on day 5 posttransplantation) was identified by expression of the proliferating cell nuclear antigen (PCNA). This observation was confirmed by bromodeoxyuridine incorporation into macrophages within the tissue. Treatment of animals with deoxyspergualin not only suppressed the degree of mononuclear cell infiltrate, but it also significantly inhibited local proliferation of macrophages within the graft (26.4 5.6% of ED1 + cells, P < 0.05 vs. untreated). This appeared to be, at least in part, a direct effect of DSP upon macrophages since the drug also inhibited growth of two monocytic cell lines (RC-2A, U937) in vitro. However, DSP treatment had no effect upon lipopolysaccharide-induced monocyte JL-l/3, TNFa, and IL-6 mRNA and protein production indicating that this drug is not a general inhibitor of monocytes. In conclusion, this study has demonstrated that local proliferation of macrophages within the kidney is a prominent feature of acute allograft rejection and that inhibition of this response is one mechanism whereby DSP exerts its potent immunosuppressive actions.
Prevalence of human T-cell leukemia virus type 1 (ffI'LV-l) antibodies in Central Australian Aborigines undergoing haemodialysis. M.G. I , :
I Kirubakaran * and L. Mollison, Department of Medicine, Alice Springs Hospita4 Alice Springs, NT-0870. Infection with HTLV-1 is common among Aborigines in Central Australia with reported prevalence rates up to 14%. Dialysis centres in endemic areas of Japan have noted higher prevalence (up to 19.7%) in haemodialysis patients, when compared to healthy blood donors (4.3%). The higher prevalence was unexplained by blood transfusions, but was suggestive of an association between HTLV-1 and chronic renal disease itself. The Central Australian Aborigines have a high incidence of chronic renal failure with unknown aetiology and we examined the sera of patients undergoing haemodialysis for HTLV-1 antibodies, in order to determine its prevalence and its possible association with the underlying renal disease. All patients undergoing haemodialysis at the dialysis unit in Alice Springs had their serum examined for HTLV-1 antibodies after informed consent. The antibodies were detected by a particle agglutination assay and positive results were confirmed with a Western blot at a reference laboratory. Of the 31 Aboriginal patients, 13 (42%) were positive for HTLV-1 antibodies. Their ages ranged from 31-67 years (mean 44.6) and 10 (77%) were males. As a group, the HTLV-1 positive patients did not differ significantly in terms of length of time on dialysis, blood transfusions, age distribution and geographical origin from the HTLV-1 negative patients. However, males were affected more often and all 6 Hepatitis B carriers in the Unit were positive for HTLV-1 also. The aetiology of renal failure was uncertain in 7 out of the 13 (54%) HTLV-1 positive patients, diabetic nephropathy in 2, obstructive uropathy in 2, amyloidosis in 1 and IgA nephropathy in 1. The 6 patients with Hepatitis B antigenemia shared two dialysis machines, but the other 7 did not show any association with the machines used for their haemodialysis. As the antibody status prior to dialysis is unknown in these patients, it is difficult to exclude cross infection as the cause of high prevalence of HTLV-1 among them, but the present data does not support this hypothesis. The strong association with renal failure of uncertain aetiology suggests that HTLV-1 may be related in some way to the renal disease in these patients. In view of the high incidence and possible aetiological association, routine screening for HTLV-1 is recommended for all Aboriginal patients prior to entry into dialysis programs.
Discontinuous use of stored BiCart dialysis concentrate does not constitute a microbiological hazard. D. W. Johnson *, J. Dale, N. Geoige, J. Faoagali, S.J. Fleming, Departments of Renal Medicine and Microbiology, Royal Brisbane Hospita4 Qid, 4029. To assess the potential bacteriological risks associated with discontinuous use of stored BiCart cartridges, total viable microbial counts were performed on 30 specimens of water used to prepare dialysate, 20 unused BiCart cartridges, 105 BiCart cartridges stored wet for 48 hours following single use and 21 samples of dialysate derived from these stored cartridges. The median bacterial counts were 89 colony forming units (CFU)/ml, 0 CFU/ml, 0 CFU/ml and <25 CFU/ml, respectively. Corresponding cultures of liquid bicarbonate concentrate before use (N = 75) and 48 h later (N = 75) together with 20 dialysate samples derived from the stored concentrates, yielded median counts of 0 CFU/ml, 0 CFU/ml and 200 CFU/ml, respectively. The most common organisms grown from all forms of dialysate or concentrate were pseudomonads. BiCart-derived dialysates universally complied with the standard of 2000 CFU/ml set by the Association for the Advancement of Medical Instrumentation (AAMI). These results indicate that discontinuous use of BiCart cartridges after storage for up to 48 hours results in relatively low levels of bacterial contamination of dialysate, and could result in significant cost reductions without compromising patient safety. tropism determined by the presence of the viral receptor (the P blood group antigen) explain these diverse manifestations of infection. Very prolonged anaemia due to persistent B19 infection has been described in immune deficient patients, and this has been treated successfully with normal pooled immunoglobulin. Recently it has been found that HIV positive patients with thrombocytopenia have a high prevalence of B19 1gM antibody. Unexpectedly, these patients may become viraemic for B19 despite prior evidence of recovery from infection (B19 IgG). It has been postulated that the replication of HIV may be able to provide permissive conditions for B19 in the bone marrow, and that the viraemia may represent reactivation of latent B19 DNA. Renal transplant patients also suffer from refractory anaemia and thrombocytopenia and are immunosuppressed. In addition they may have received prior erythropoietin which could stimulate red cell precursor turnover and allow reactivation of B19.
To seek evidence of B19 reactivation in another clinically significant setting we have performed B19 1gM and IgG serology on pre-and post-transplant sera from 36 patients. 24 were B19 IgG positive pretransplant which is comparable with the rate in blood donors. B19 1gM was present in 9 post transplant sera and 6 of these were IgG positive earlier. 2 other patients were viraemic as judged by B19 PCR. B19 sequences are being sought in bone marrow aspirates from patients with and without serological evidence of virus activation or clinical bone marrow suppression.
The comparative efficacy of 3 regimes of i.v. iron dextran in haemodialysis (HD) patients treated with erythropoietin (EPO). D. Saltissi*, D.
Sauvage, J. Westhuyzen, Department of Renal Medicine, Royal Brisbane and Keperra Hospitals, Brisbane, Queensland. Uraemic anaemia is primarily due to relative EPO deficiency. The demand for new red cells is most marked in HD patients due to constant blood, thus iron losses. rHuEPO administered parenterally alleviates uraemic anaemia, but the response is blunted by several factors including most commonly, iron deficiency. In many cases parenteral iron has been shown necessary to restore EPO efficacy, but the optimum time course of administration is unknown. We
have performed an open randomised study of IV. Iron Dextran (Tmferon*) in 60 deficient patients (ferritin <100 jrg/L and/or transferrin saturation <20%). Elemental iron was administered either as a single 600 mg bolus (A), or 100 mg weekly for 6 weeks (B), or 100 mg on 6 successive dialyses (C) (20 patients each). Haematological response was monitored for eight weeks. Statistical analysis indicates all 3 methods have an effect on iron parameters, with the upward trend of Hb reaching significance (P < 0.01). As there were no differences between the methods, single dose infusion (method A) would seem most expedient. * Registered Trademark, Fisons Pty Ltd. Vic. There are many potential dialyser variables which may influence patient well-being and tolerance of dialysis. In an attempt to isolate two of these factors we utilized cuprammonium dialysers in three different conformations, 5 times each in 5 patients. The "baseline" was ethylene oxide (ETO) sterilised, standard cuprammonium membranes. The variables included were a change to steam sterilisation (SS) and then the addition of "high-flux" cupramnionium membranes (HF) which were also steam sterilised. The clinical variables measured for all dialyses were BP (pre and post dialysis), weight loss achieved, dialysis related symptoms, and temperature rise. During the 5th dialysis instantaneous dialyser urea clearance (measured 1 hour into dialysis at 200 mI/mm blood flow), and 132 microglobulin clearance (corrected for protein concentration, expressed as percent reduction) were measured. Plasma was also obtained for pre and post dialysis IL-1/3 and TNFa assessment (by ELISA). There were no differences in BP or temperature rise between the 3 groups. There were more symptoms with the SS group compared to the other 2 groups (though not significant, P = 0.1). Instantaneous dialyser clearances were significantly better with the HF dialysers (174 6 mI/mm with ETO, 178 2 with SS, and 184 1 with HF; P < 0.05 HF vs. ETO or SS). f32m clearances were negligible with ETO and SS dialysers but were 18.6 3.5% with the HF group (P < 0.05 vs. ETO or SS). IL-1f3 and TNFn plasma levels were mildly elevated predialysis, did not rise with dialysis, and showed no difference between the groups. Thus steam sterilisation alone offered no benefit in this group of patients and the high-flux version of cuprammonium dialysers offered significantly improved urea clearances but still only fair J32m clearance. Cytokines were not significantly induced over the course of dialysis by any of the membranes. Choice of these more expensive membrane variables cannot be recommended on biocompatibility grounds.
Sclerosing peritonitis-Identification of diagnostic, clinical and radiological features. S. Campbell*, C. Hawley, P. Clarke, M Wigan, P. Kerlin, J. Butler and D. Wall, Departments of Renal Medicine, Radiology, Gastroenterology and Surgeiy, Princess Alexandra Hospital, Woolloongabba, Brisbane, 4102. Sclerosing peritonitis is a rare, but serious complication of peritoneal dialysis. In an attempt to identify patients at risk of developing this life-threatening problem early, we performed a cross-sectional study of 15 patients. Five had died of sclerosing peritonitis. Four had stopped peritoneal dialysis because sclerosing peritonitis was suspected. Six were considered to be at increased risk because of more than four years on peritoneal dialysis. We looked at duration of dialysis, number of episodes of peritonitis, strength of bags, as well as type of dialysate and use of beta-blockers. We also used a number of radiological investigations, including abdominal x-ray, a measure of colonic transit using radioopaque markers, abdominal ultrasound and CT-scan. Of the clinical features, only duration of dialysis could be shown to be an important risk factor. We identified a number of radiological features which we believe to be early signs of peritoneal sclerosis. The two CT-scans that were available from deceased patients, demonstrated peritoneal thickening, as did those in three of the four living patients who stopped peritoneal dialysis with suspected disease, and two of the six patients on peritoneal dialysis for over 4 years. Ultrasound demonstrated a characteristic trilaminar appearance in four patients, but was unable to be demonstrated without Nform antibody is produced by dialysis patients following reuse of dialysers sterilised with formaldehyde and it has been implicated as a cause of haemolytic anemia. Formaldehyde is one of the common disinfectants used for reprocessing capillary haemodialysers. The safety of formaldehyde and the clinical significance of anti-Nform antibody need further evaluation. Amongst 45 patients practising dialyser reuse, anti-Nrm antibody was detected in 5 (11.1%), but not amongst 111 patients not reusing their dialyser (P < 0.005). The presence of anti-N,,, was not related to duration of dialysis or duration of dialysis with reused dialysers. There was no overt haemolysis in the patients with positive anti-Nform antibody, although significant haemolysis occurred in one patient prior to this study. Direct Coomb's test was positive in 80% of all tested patients with anti-Nform antibody, and in 38% of patients reusing dialysers but without anti-Nform antibody. No test of haemolysis (including direct Coomb's test) discriminated between anti-N,,rm antibody positive and negative patients, nor between anti-N1,,.,,, antibody patients with and without overt haemolysis. The best diagnostic test for haemolysis in anti-Nform antibody positive patients is haematocrit rise after cessation of dialyser reuse.
Evaluation of the UV-Flash germicidal exchange device for use in peritoneal dialysis (PD). D. Saltissi*, M.J. King, Department of Renal Medicine, Royal Brisbane and Keperra Hospitals, Brisbane, Queensland. Numerous techniques have been devised in attempts to reduce peritonitis incidence with chronic PD. The UV-Flash (Baxter*) is a recent development combining automated spike-bag connection with Xenon Ultraviolet sterilisation. In a 12 mth prospective randomised cross-over study we have investigated peritonitis incidence and patient acceptability of the UV-Flash compared to "other" systems. 24 new pts (13 M, 11 F; age 27-80, mean 57 yrs) were randomly allocated UV-Flash (12 pts) or "other" system (Ultraset 4, System III 4, CXD 4) and crossed after six months.
Results:
UV-Flash "0ther" System
Episodes Peritonitis
Overall Peritonitis 1st 6m 2nd 6m 10 (lopts) 0 (Spts) 1:9.96 mth 4 (4pts) 2 (pts) 1:14 mth rate P = NS 10 pts did not complete the two study periods, reasons will be discussed. Numerous technical problems were initially encountered, all were eventually rectified. Elderly patients tended to fear the device. Cost per annum: UV-Flash, $14,700, System III $14,000, Ultraset $20,000. We believe the UV-Flash has a place particularly for patients with visual and manual dexterity problems.
Low molecular weight heparin use in haemodialysis: A comparison with standard heparin and a cost-analysis. Nicola M. Hay* and Robyn J.
Caterson, Department of Renal Medicine, Royal North Shore Hospita) St. Leonards, NSW2O6S, Australia. A stable patient group receiving treatment at a satellite dialysis unit was assessed with regard to anticoagulant use during haemodialysis. Heparin is the standard anticoagulant used to prevent clotting in the extracorporeal circuit, given as a bolus injection at the start of dialysis followed by a continuous infusion. Low molecular weight heparin (Fragmin') has a longer half-life allowing for more convenient administration as a single injection given at the start of dialysis only. No monitoring of clotting factors is required with either regimen.
Twenty-seven patients (11 males) with a mean age of 51 years (range 25 to 77) were assessed over a three month period. In the group receiving conventional heparin (N = 18) the cost was calculated as $1.77 per dialysis treatment, The mean "compression time" was 9.14 minutes (range 2.5-16.25). Nine patients received Fragmin', 6 receiving 2500 anti-Xa units ($3.80) and 3 requiring 5000 anti-Xa units ($7.58). The mean "compression time" was 8,62 minutes (range 3.8-13.3). There were no bleeding complications with either treatment. When a patient requires minimal anticoagulation monitoring of whole blood clotting times is required if low dose heparin is given. This results in a significantly greater cost of $10.92 compared to treatment with 1250 anti-Xa units of FragminR ($3.80). Our observations suggest that it is clearly not cost-effective to use FragminR during routine haemodialysis, however, there is a cost advantage when minimal anticoagulation is required. FragminR is a safe, convenient, and effective but expensive alternative to standard heparin used during haemodialysis.
Effect of enalapril on haemorheology in hypertensive patients with renal disease. B.I. Shand, * R.R. Bailey, KL. Lynn and R.A. Robson, Department of Nephrology, Christchurch Hospital Christchurch. We assessed prospectively, whether the angiotensin converting enzyme inhibitor (ACEI), enalapril, caused changes in haemorheology (blood viscosity) in hypertensive patients with renal disease. Cellular and plasma determinants of blood viscosity, renal function and blood pressure were tested at baseline and 2, 60 and 120 days following treatment with enalapril (mean dose 5.4; range 2.5-20 mg/day) in 19 patients with a range of renal disorders with complicating hypertension. None of the patients was taking other antihypertensive medication or diuretics during the study and all other therapy remained unchanged. Approximately one-half of the patients had an abnormal baseline blood rheology profile. Within 2 days following enalapril treatment there was a significant decrease in blood viscosity (-0.15 mPa.s; P < 0.05), followed by a further fall of similar magnitude by day 60, which was unchanged by day 120. The initial decrease in blood viscosity correlated significantly with a concurrent fall in mean plasma viscosity (r = 0.80; P = 0.001) and plasma albumin concentration (r = 0.49; P = 0.01), indicating haemodilution had occurred secondary to ACEI-induced vasodilatation. The later further reduction in blood viscosity was mainly associated (r = 0.82; P = 0.001) with a small but significant fall in haematocrit (-0.02; P = 0.01) and also to a trend of improved red blood cell and white blood cell rheological properties. We conclude, that enalapril has a beneficial effect on haemorheology in patients with renal disorders. This effect is related, initially to intravascular volume changes and subsequently, to a small decrease in haematocrit and improved blood cell rheological properties. The decrease in blood viscosity would be expected to reduce vascular resistance to blood flow and therefore is complementary to the antihypertensive action of enalapril. Christchurch. We have shown previously that angiotensin converting enzyme inhibitors (ACEI5) cause small reductions in haematocrit in healthy subjects, associated with a decrease in plasma erythropoietin (EPO) concentration. We studied this effect prospectively in 19 hypertensive patients (mean age 47 11 yr; 14 males) with a range of renal diseases who were treated with enalapril. Blood samples were obtained at baseline and at 2, 60 and 120 days following administration of enalapril (mean dose 5.4; range 2.5-20 mg/day) and tested for haematological indices, plasma EPO (measured in duplicate by radioimmunoassay) and plasma creatinine concentrations. By day 60 there was a decrease in haemoglobin concentration (mean decrease 7.4 WI; P = 0.03) that was sustained until day 120. The magnitude of the decrease in haemoglobin concentration correlated significantly with the baseline plasma creatinine concentration (r = -0.606; P < 0.01). A decrease in plasma EPO concentration occurred by day 2 (mean decrease 16.8%; P = 0.04) followed by a return to baseline. The changes in plasma EPO concentration of individual patients, were not related to either the dose of enalapril, baseline haematological status or renal function, or to the subsequent decrease in haematocrit. These results suggested that the degree of renal impairment was important in determining the magnitude of the decrease in eiythropoiesis associated with ACE inhibition. The mechanism of these haematological changes however remains unclear. Our findings are consistent with other studies that have demonstrated that angiotensin II is necessary for the maximal production and Low protein diet is not protective in the remnant kidney model. *AM Walker, N.M. Thomson, Dept. Medicine, Monash Medical School, Alfred Hospital, Prahran, Melbourne, Vic., Australia, 3181. Low protein diet has been demonstrated to inhibit compensatory renal growth (CRG) and slow the development of renal failure and glomerulosclerosis in rat remnant kidney model of chronic nonimmune injury. 12 week old, male inbred SD underwent either 7/8 nephrectomy by infarction (Nx) or sham laparotomy (Sh). Rats were randomly assigned to receive standard protein diet (25% protein) (St) or low protein (8%), isocaloric diet (LP). Growth, blood pressure and renal function was followed for 12 postoperative weeks. Systolic blood pressure was measured by tail-cuff method and renal function estimated by sCr, Cr. clearance and urinary protein excretion. Animals were killed at regular intervals over a 12 week period and tissue assessed for histological damage. Low protein diet following Nx was associated with somatic growth failure (332 9 g LPNx, 366 8 g Nx at 9 w) and the early development of severe hypertension (200 mm Hg LPNx, 150 mm Hg StNx, 120 mm Hg LPSh & StSh) by 4 w. Renal function was similar for the first 4 weeks but then deteriorated more rapidly in those animals receiving the LP diet: sCr 180 75 mmol/l (LPNx), sCr 118 21 mmol/l (StNx) at 8 weeks. Most animals receiving LP diet were in end stage renal failure by 11 w. Histological analysis revealed similar degrees of glomerular hypertrophy between the dietary groups (47 2% glom LPNx, 50 5% glom. StNx at 9 weeks). Percent glomeruli demonstrating sclerosis was less in the LPNx group despite worse renal function when compared to StNx dietary group (11 2% LPNx, 21 6% StNx at 9w).
Effect of enalapril on haematological indices and plasma erythropoietin
Although there appeared to be more severe tubular damage and dilatation in LP diet animals, tubulointerstitial index was similar between the groups.
It is unclear why dietary modification with low protein, isocaloric feed would lead to such severe hypertension and renal deterioration following 7/8 Nx.
Cancers of the renal pelvis are more malignant when associated with phenacetin-containing analgesics: Evidence for a carcinogenetic-promoting effect of papillary necrosis. J.H. Stewart*, J.B. Hobbs and Margaret
McCredie, University of Sydney, Nepean Hospital and NSW Cancer Council, P0 Box 63, Penrith, NSW, 2751. The histopathological slides of 101 kidneys with pelvic cancer, drawn from a population-based sample of 147 respondents to a questionnaire eliciting information concerning exposure to risk factors for kidney cancer, were reviewed 'blind' to the exposure status of the cases. Papillary necrosis (odds ratio-OR--6.3), papillary calcification (OR 3.7) and diffuse papillary scarring (OR 4.4) were significantly (P < 0.02) associated with heavy consumption (>1 kg) of phenacetin-containing analgesics, but focal papillary scarring and ureteric submucosal capillarosclerosis were not. The overall histological (ASH) and nuclear grades of the transitional-cell carcinomas (TCC) were significantly (P < 0.02) higher, but there was no increase in squamous metaplasia nor squamous-cell carcinoma, in analgesic-associated cancers. Neither the histological grade of cancer nor the degree of squamous change was related to smoking tobacco. Multivariate logistic regression identified female sex (OR 4.8; possibly representing confounding factors), papillary necrosis (OR 4.7) and diffuse papillary scarring (OR 5.7), but not heavy analgesic consumption, as independent factors significantly associated with a higher grade of malignancy. These observations support the concept that an important part of the carcinogenetic effect of heavy consumption of phenacetin-containing analgesics is promotion by the papillary damage so caused. December 1992 74 women in the 15-45 yr age group had a total of 93 transplants in this institution. During this time 16 pregnancies were recorded in 9 of these women. Fourteen of the pregnancies were planned.
These resulted in 11 live births and 3 first trimester abortions. The remaining 2 were unplanned and were terminated. Mean age at transplantation of these 9 women was 17.2 [sn 6.8; range 16-22.5] yr and mean interval from transplant to pregnancy was 6.0 [SD 3.7; range 0.2-9.0] yr. Thirteen pregnancies occurred in 7 women with a cadaveric kidney and 3 pregnancies in 2 women who had received a kidney from a living-related donor. Prednisone and azathioprine were used in all patients and cyclosporin in 5 of the pregnancies. For 7 of the successful pregnancies the pre-conception plasma creatinine was 0.10 mmol/l and was unchanged after delivery. One of these women developed chronic rejection 5 yr after delivery and reached endstage renal failure 9 yr later. For the other 4 successful pregnancies the pre-conception plasma creatinine was 0.12 to 0.14 mmol/l. One of these patients halved her renal function, but this has remained stable for 15 yr. 1 poorly compliant woman developed chronic rejection after delivery and reached endstage renal failure 2 yr later, 1 developed cyclosporin toxicity and the other was unchanged. Six deliveries were by elective caesarean section, 4 by urgent caesarean section and 1 by vaginal delivery. There were no congenital anomalies or perinatal mortality. One infant died aged 4 mth from a cot death. We recommend that if a woman has had a stable renal transplant for >2 yr, graft function is normal, and BP well controlled then there is no contraindication to her having a pregnancy which should be managed by shared obstetrical/ nephrological care. [SD 70.6] mth; range 3-258 mth) from a temperate maritime climate, latitude 42°S, with regard to sun exposure, skin type and human papillomavirus (HPV) type of clinically apparent warts. All skin infections were characterised and miscellaneous cutaneous lesions recorded. Thirty-seven patients were on a regimen of prednisone and azathioprine and the remaining 18 on prednisone, azathioprine and cyclosporin. Forty-three (84%) were regular users of sunblock with a sun protection factor rating of 15. Premalignant and malignant lesions were common (20 actinic keratoses, 3 BCC, 2 KA, 1 melanoma). Including prior observations 48 cutaneous malignancies were identified in 9 patients. Squamous cell carcinoma outnumbered basal cell carcinoma by a ratio of 1.2:1. No metastases were recorded. Non-neoplastic lesions were also documented including the prevalence of HPV infection. There was a significant correlation between the development of skin cancer after transplantation and total sun exposure (P < 0.05), clinically apparent wart infection (P < 0.05), and the duration of unmunosuppression (P < 0.01). Renal transplant recipients require regular skin examination. High risk patients for skin cancer should be identified as they require intensive mice. This was associated with rapid accumulation of neutrophils in glomeruli which peaked at 1 hour (6.2 0.5 neutrophils per glomerular cross section [neut/gcs], normal 0.34 0.06 neut/gcs, P < 0.01) and significant proteinuria after 16 hours (3.6 0.5 mg/16h, control 0.62 0.13 mg/16h, P < 0.01). Complement depletion with cobra venom factor, which reduced serum C3 levels to less than 5% of normal, did not alter expression of P selectin, reduce glomerular neutrophil accumulation (6.7 0.8 neut/ges) or proteinuria (3.7 0.5 mg/16h). Platelet depletion also failed to alter glomerular expression of P selectin, neutrophil accumulation or the development of proteinuria. Mice were treated with an affinity purified anti-human P selectin antibody, which crossreacted with mouse P selectin and blocked P selectin dependent binding of thrombin activated mouse platelets to HL6O cells. Treatment, 1 hour prior to administration of anti-GBM antibody, markedly inhibited glomerular neutrophil accumulation (0.94 0.12 neut/gcs) and prevented proteinuria (1.0 0.2 mg/16h), and did not alter binding of anti-GBM globulin in the kidney.
These data strongly suggest that the rapid upregulation of P selectin expression in glomeruli following binding of anti-GBM antibody is an essential signal for neutrophil recruitment in this complement independent model of glomerular injury.
Suppression of established rat crescentic glomerulonephritis (GN) by the interleukin-1 receptor antagonist (IL-ira). H.Y. Lan, D.J. Nikolic-Paterson, W. Mu, R. C. Atkins, Dept. of Nephrology, Monash Medical Centre, Clayton Vic 3168, Australia. We have previously demonstrated that IL-ira treatment from the time of anti-GBM serum injection suppressed the development of accelerated rat anti-GBM GN. The current study investigated whether IL-ira treatment could intervene in established crescentic GN. Accelerated anti-GBM GN was induced in inbred Sprague-Dawley rats by priming with 5 mg normal rabbit IgG and injection of rabbit anti-rat GBM serum 5 days later (day 0). One group of 6 rats received a constant subcutaneous infusion of IL-ira from day 7 until being killed at day 21. Control animals have the same experimental schedule but received saline only (untreated). Blood and urine samples were taken on days 0, 1, 7, 14, and 21. Leukocyte infiltration was assessed by immunoperoxidase staining with monoclonal antibodies. Saline treated animals showed marked disease progression over days 7 to 21 which was significantly reduced by IL-ira treatment. Specifically, IL-ira treatment reduced hematuria (P < 0.001), proteinuria (P < 0.05), and plasma creatinine while improving creatinine clearance (P < 0.05, by ANOVA). Histologically, IL-ira treatment markedly reduced glomerular hypercellularity and segmental sclerosis ( , 50%, P < 0.01), cell proliferation ( 53% of PCNA cells/gcs, P < 0.001), glomerular crescents (58.5 4.9% vs. 25 3.6%, P <0.01), and tubulointerstitial fibrosis (P < 0.05). Immunohistologically, IL-ira treatment suppressed glomerular ( t. 42%, P < 0.01) and interstitial (1. 64%, P < 0.001) macrophage accumulation and interstitial T cell accumulation (,j, 37%, P < 0.01). Importantly, IL-ira suppressed interstitial mononuclear cell activation (J, 64% IL-2R cells, P < 0.01). This study demonstrates that IL-ira can intervene in progressive renal injury in experimental crescentic GN.
Reactive oxygen species (ROS) and lipid peroxidation (LPO) in proteinuric experimental renal disease. TJ. Neale*, D. Kerjaschki#, J. Witztumt, P. Davis, B. Ruger, Dept. of Medicine, Wellington School of Medicine, #Institute of Pathology, University of Vienna and fDepartment of Medicine, UCSD, San Diego. ROS are implicated in the pathogenesis of experimental glomerular injury. In proteinuric passive Heymann's nephritis (PHN), glomerular epithelial cells (GEC) show heightened expression of cytochrome b558, a component of the respiratory burst oxidoreductase that produces ROS (Proc NatlAcad Scj USA 90:3645-3649, 1993) . Cytochrome b558 also showed increased expression in the GEC of amminonucleoside nephrosis (AN) rats, by monoclonal IF microscopy and immunoblotting of isolated glomerular extracts. There was marked upregulation of cytochrome mRNA by Northern blotting. H2O2 was localised by EM within the glomerular capillary wall using ex vivo perfusion with cerium. In proteinuric AN and PHN glomeruli malondialdehyde (MDA) was revealed as a marker of LPO with antibody specific for MDA-lysine adducts by IF microscopy, immunogold EM and immunoblotting. MDA was present on cell membranes, within GEC vesicles and associated with GBMs. Type IV collagen was a recipient of MDA adducts as shown by autoradiography of immunoprecipitates of isolated GBMs from proteinuric PHN rats which were specifically H3-Iabelled in their MDA-derivatised proteins. Anti-MDA antibody bound to type IV collagen immunoprecipitated from glomerular extracts. Collagenase treatment of GBM extracts indicated that the NC-i domain of type IV collagen was a site of adduct formation. Inhibition of LPO in vivo by pretreatment of rats with the lipophilic antioxidant probucol markedly abrogated proteinuria compared to controls in both models: (PHN: 24.8 8.0 versus 161 24 mg per 24 hrs; P = <0.05; AN 28 6 versus 186 8mg per 24 hrs; P <0.01). The glomerular IF signal for, and whole kidney [MDAJ (P < 0.01) were markedly reduced compared to controls. These findings strongly implicate LPO in the production of the altered glomerular permselectivity that results in proteinuria in PHN and AN. gene has a role in acute and chronic renal injury that is not well understood. Its increased expression is often associated with presence of apoptosis, but some reports demonstrate links with the renal regenerative response found after toxin-or ischaemia-induced acute tubular necrosis. We have used a novel rodent model of renal regeneration to study SGP-2 expression and intrarenal distribution. The model involved initial development of unilateral non-infarctive renal atrophy using experimental renal artery stenosis, followed by contralateral nephrectomy after several weeks. Regeneration of remnant atrophic kidneys was rapid and involved renal cellular hyperplasia rather than hypertrophy. At the time of induction of regeneration, cellular pathology of atrophic kidneys comprised regions of shrunken de-differentiated tubules, an expanded interstitium, and focal hypertrophied but otherwise normal tubules. Apoptosis, which is known to play a major role in earlier development of renal atrophy, was rarely visible, and there was little inflammation. Regenerating renal tissue from male rats (N = 2 or 3) was studied at 0, 4, 8, 24 hours, 2, 3, 5, 7, and 14 days after contralateral nephrectomy. Control animals were sham-operated (N = 2). Several parameters were studied: level and localisation SGP-2 expression (Northern blots and in situ hybridisation); cell proliferation (PCNA immunolocalisation and histological identification of mitosis); and apoptosis (morphological characteristics). During the acute regenerative phase (first 24 hours) expression of SGP-2 was increased, decreasing to untraceable levels by 3 days. Expression was localised most often in dc-differentiated atrophic tubules, or the periphery of vessel walls. PCNA counts peaked at 5 days, with epithelial cells of dc-differentiated atrophic tubules again most active. Despite the regenerative stimulus, an unexpected but marked transient increase in apoptosis was found in atrophic tubules in the first 2 days. Thus, the results provide evidence that increased expression of SGP-2 is associated with apoptosis rather than regeneration, but a role in restructuring of the atrophic tissue cannot be ruled out. The results also suggest that this model may be useful for studying other early genetic changes found in renal neoplasia.
Regulation of the integrin fibronectin receptor a5j31. Implications for mononuclear cell accumulation at sites of inflammation. RandallJ. Faull* and Mark H. Ginsberg, Department of Renal Medicine, St. George Hospital, Kogarah, NSW, 2217, and Committee on Vascular Biology, The Scnpps Research Institute, La Jolla, California. Disorders dependent on mononuclear cell accumulation at inflammatory sites are frequently encountered in nephrology. They include rejection of allografts, vasculitis, glomerulonephritis, tubulo-interstitial nephritis and pyelonephritis. Cells migrating from the blood to these sites undergo repeated cycles of attachment! detachment to the vascular endothelial cells and the extracellular-matrix. Principal among the cell surface receptors mediating these interactions are members of the integrin superfamily of adhesion molecules, including the "classical" fibronectin receptor a5f34. We have studied the regulation of a51 function on mononuclear cells in order to assess its contribution to this process of extravasation and accumulation. A monoclonal antibody (8A2) directed against the j3 chain directly activated the a51 receptors, converting them from a conformation with low affinity for soluble fibronectin (Kd > 1 tM) to one with high affinity (Kd 40 nM). In the presence of soluble fibronectin at a concentration found in normal plasma (700 nM), these high affinity receptors were occupied and unable to mediate adhesion of T lymphoid cells to immobilised fibronectin. In contrast, stimulation of protein kinase C in T lymphoid cells with phorbol myristate acetate increased adhesion to fibronectin by inducing cell spreading. As the receptors remained in a low affinity conformation, the increase in adhesion was not blocked by soluble fibronectin. The findings suggest that only the low affinity receptors are available for adhesion in the presence of physiological concentrations of soluble fibronectin. Both forms of the a31 are presumably physiologically relevant, as differentiation of monocytoid cells (THP-1) into adherent, macrophage-like cells induced a subpopulation (30%) of high affinity a5f31 receptors. We hypothesize that: (1) mononuclear cells use the low affinity a5f31 receptors for the reversible interactions required during migration into inflammatory foci; and (2) the high affinity receptors induced by the subsequent differentiation bind soluble fibronectin, enabling the cells to assemble a stabilising fibronectin matrix and hence persist at those sites. The present study examined whether adhesion molecules ICAM-1 and VCAM-1 may be involved in glomerular M4i infiltration in ExHC rats-a strain which is susceptible to lipid-induced glomerular injury (Nephron 63:314, 1993) . Twenty-five male 6 week old ExHC rats were placed on a normal diet supplemented with 3% cholesterol, 0.6% sodium cholate and 15% olive oil (HCD). Groups of 5 rats were killed after 3 days, 1, 2, and 6 weeks on HCD diet. A group of 5 matched ExHC rats on a normal diet served as a control. HCD rats showed marked hypercholesterolemia in the absence of any increase in plasma triglyceride levels from day 3 (190 14 vs. 41 3 mg/dl normal; P < 0.01), and developed mild proteinuria (21.9 2.7 vs. 5.2 0.5 mg/24 hours normal; P < 0.01) and segmental glomerular lesions at week 6. Immunoperoxidase staining identified a significant increase in glomerular ED1 + M4 at week 1 which was further increased at week 6 (6.9 0.4 vs. 1.0 0.1 ED1+/gcs normal; P < 0.01).
There was also a significant increase in glomerular cells expressing the adhesion molecule ligands LFA-i and VLA-4. Coincident with M4 infiltration there was an increase in glomerular anti-ICAM-1 staining in both the number of positive cells and the intensity of staining. Northern blot analysis of cortical RNA found an increase in both ICAM-i and VCAM-1 mRNA from day 3 onwards. In conclusion, these results suggest that upregulation of ICAM-1 and VCAM-1 expression may play an important role in lipid-induced glomerular M infiltration.
Plasminogen activator inhibitor type-i in rabbit crescentic glomerulonephritis: Assessment of function and association with fibrin deposition. J.H. Erlich*, J. Malliaros, J.A. Apostolopoulos, SR. Holdsworth & PG. Tipping, Department of Medicine, Monash University, Clayton, Vic 3168, Australia. Plasminogen activator type-i (PAl-i) is a naturally occurring rapidly acting inhibitor of the plasminogen activators-tissue plasminogen activator (t-PA) and urokinase plasminogen activator (u-PA). Endothelial cells are a major source of PAL-i. The role of PAL-i in antiglomerular basement membrane (anti-GBM) glomerulonephritis (GN) was investigated in a rabbit model of anti-GBM GN characterised by: proteinuria, renal impairment, crescent formation, fibrin deposition and macrophage influx. Rabbits were presensitised with a subcutaneous injection of normal horse immunoglobulin followed 5 days later by 25 mg/kg of horse anti-rabbit-GBM antibody intravenously. Renal tissue was collected after 1, 4, 7, and 12 days. Fibrin deposition in isolated rabbit glomeruli was assessed following injection of 1251-fibrinogen and by fibrinogen immunofluorescence in rabbit renal cortical sections. At each time point PAl-i activity was assessed in conditioned medium of cultured glomeruli using a urokinase functional inhibition assay and PAl-i mRNA expression was determined using RNA isolated immediately from glomeruli. PAL-i activity in glomeruli was increased on days 4 (291 18 au) (mean saM) and day 7 (213 27 au) (P < 0.05 cf normal 112 38 au). This correlated with an increase in glomerular PAl-i mRNA which was also increased on days 4 (123.4 7.3) and 7 (133 2.6) (P < 0.084 day 4 cf normal; P < 0.021 day 7 cf normal). The increase in PAl-i activity and mRNA showed the same temporal pattern as glomerular fibrin accumulation and macrophage infiltration on days 4 (21.8 3.3 g/10' glomeruli) and day 7 (20.0 2,5 .tg/10' glomeruli) (P < 0.05 cf normal 1.5 0.5 .rg/i03 glomeruli). This close temporal correlation between glomerular PAL-i function, often poor in children with chronic renal failure. In order to provide optimal nutrition, it is necessary to know the energy requirements of this group. The aim of this study is to determine the resting energy expenditure (REE) in a group of children with glomerular filtration rate (GFR) <30 mI/mm/i .73 m2 and to compare this with the predicted REE according to Schofield1. REE was measured with a flow through ventilated hood open circuit indirect calorimeter in six children after an overnight fast. Energy intake, measured by a 4 day weighed food record, was compared to WHO/FAO recommended energy intake for age. Mean age was 10.8 years, mean height standard deviation score (SDS) was -1.75 and mean weight SDS was -1.06. The mean REE was 98.1% of the predicted REE. Mean energy intake was 88.6% of recommended. Resting energy expenditure is normal in these children with chronic renal failure. However energy intake is below that recommended for children with a normal REE.
Malnutrition and growth failure may result if energy intake is not increased to meet energy expenditure. Nutritional support for children with renal failure should be planned to provide the recommended energy intake for age.
1. SCHOFIELD WH, ET AL.: Basal metabolic rate-review and prediction. Human Nutrition: Clinical Nutrition 39C:1-96, 1985
Amyloidosis among Central Australian Aborigines. MG. Kirubakaran*, N Rajabalendran and L. Mollison, Department of Medicine, Alice Springs Hospital, Alice Springs, NT-0870. The incidence of amyloidosis varies greatly between different ethnic groups throughout the world and it is particularly high in the Aboriginal population of Central Australia.
Nineteen new cases of amyloidosis were detected during a six year period among a population of 13,200 Aborigines in Central Australia, giving an incidence of 240 cases per million per year. The mean age was 43.5 years (range 26-72) and 11 were females. The main presenting symptom was acute abdomen with pseudo-obstruction in 12 cases, five of whom had exploratory laparotomy prior to diagnosis. Multiple organisms were grown from the peritoneal fluid in all 5 cases. The diagnosis of amyloidosis was established by renal biopsy in 9 cases, rectal biopsy in 7 and at post mortem in 3. The amyloid was AA type in all cases but chronic infection was present only in 4 cases (pulmonary tuberculosis, chronic osteomyelitis, lepromatous leprosy and extensive donovanosis-1 case each). Eleven patients have died, 8 within 6 months of onset of symptoms. Overwhelming infection with multisystem failure was the main cause of death, aggravated by malabsorption and malnutrition. Post mortem findings were similar all cases available for autopsy with widespread amyloid deposits in all the internal organs. End stage renal failure developed in 8 patients, all of whom were commenced on dialysis, and two have been transplanted. The Central Australian Aborigines have a very high incidence of AA type of amyloidosis and the aetiology remains obscure in most of them. The disease appears to have a fulminant course with high mortality and morbidity.
Validation of screening of children for renal abnormalities. S.J. Hams', MP. Dixit, R.J. Hog,g P.H. Henning, N Wigg & KF. Jureidini, Renal Unit, Women's & Children's Hospital and Child Adolescent Family Health Services , Adelaide, South Australia 5006. We have previously screened 8764 kindergarten children for renal abnormalities by measuring BP, growth percentiles and testing frozen first morning urine for blood, protein, glucose, osmolality, nitrites and f32-microglobulin. 978 (11.3%) of these showed abnormalities and were reviewed in the renal clinic with full history and examination, repeat urine assays and renal ultrasound, where indicated. Of these, 86 (8.8%) were ultimately shown to have significant abnormalities. Screening has been performed on a further 690 kindergarten children. Of these 77 (11.3%) initially screened abnormal and 11 (14.3%) were ultimately proven significantly abnormal. 347 children, normal on initial screen, were recalled. On review in the renal clinic, 2 (0.6%) were proven to have significant abnormalities (one had dominant polycystic kidneys with a positive family history, normal BP and urinalysis and the other a normotensive co-arctation of the aorta with obviously diminished femoral pulses on examination). The study shows a significant difference in ultimate diagnosis of renal abnormalities between those showing changes on the primary screen compared with those who do not (8.8% cf 0.6%, P < 0.001). This, coupled with the similar abnormality rate in this recent screening compared with the previous larger study, suggests the validity of our screening methods.
Haematuria and urinary red blood cell morphology. P. Sizeland*, R.R.
Bailey, B. Harns Departments of Nephrology and Microbiology, Christchurch
Hospital. Urinary red blood cell (rbc) morphology is widely used in the evaluation of haematuria. Some concerns persist with the technique, however, including the lack of a precise classification of rbc morphology and the proportion of cells with abnormal morphology that constitutes glomerular haematuria. Using a recently described morphological classification (Tomita et al., Clin Nephrol 37:84-9, 1992) , we evaluated the technique in the differential diagnosis of urinary tract haematuria. Results are shown in Table 1 Using readily available laboratory results (proteinuria, casts, plasma creatinine), in addition to urinary rbc morphology, improved precision as shown in Table 2 : with copper. This is expressed as lag time (mm) between addition of copper and commencement of oxidation. The change in Absorbance represents conjugated diene formation and correlates with the presence of products of oxidation. Thus, a long Lag phase and low A Absorbance are associated with a lower risk of atherogenesis. HD and PD patients had higher Triglyceride levels than C (P = 0.03, P = 0.01 respectively). KidTx had lower Triglyceride levels than PD (P = 0.01) and a trend for lower Triglyceride levels than HD. KidTx had higher Cholesterol levels (P = 0.001) when compared with HD. There was no difference in the Lag time between HD, PD, and C. HD had increased products of oxidation as measured by A Absorbance (P = 0.0002 ci C and P < 0.0001 cf PD). It is possible that the Haemodialysis procedure itself may contribute to a lower antioxidant state and thus result in increased lipid peroxidation in this group of patients. With the restoration of renal function after transplantation, the elevated A Absorbance returns to normal. This may contribute to a reduction in atherogenicity and vascular disease. Plasma CET rate was higher in hyperlipidemic subjects with the highest rates in the CAPD group. In the normolipidemic subjects there was no difference compared to controls. Plasma apo-B levels correlated with CET rates in all renal patients (r = 0.754 P < 0.001). This study shows that plasma CET rate is closely associated with apo-B and lipid levels irrespective of treatment modality. Raised CET activity may not be inevitable in CRF as activity was normal in absence of hyperlipidemia.
What influence lipid lowering therapy may have on plasma CET activity in hyperlipidemic patients with CRF warrents further investigation. Serum lipoprotein (a) concentrations were greater than 300 mg/I in 24% of the renal transplant recipients and 40% of the dialysis patients, and other potentially atherogenic lipid abnormalities were very prevalent. In the renal transplant recipients, lipoprotein (a) correlated with age (P < 0.001) and inversely with azathioprine dosage (P < 0.01). Low HDL cholesterol concentrations (P < 0.05) and high total cholesterol to HDL cholesterol ratios (P < 0.01) were more strongly associated with the presence of vascular disease than was elevated lipoprotein (a). In the dialysis patients, a low serum albumin (P < 0.05) and a low serum creatinine (P < 0.001), indicative of a poor nutritional state, were associated with the presence of vascular disease. A high total serum cholesterol to HDL cholesterol ratio (P < 0.05) was indicative of ischaemic heart disease, and a high total serum cholesterol (P < 0.01) and LDL cholesterol (P < 0.01) of cerebrovascular disease. Although patients on CAPD (N = 21) tended to have higher serum lipoprotein (a) compared with patients on haemodialysis (N = 39), i.e. 403 76 vs. 260 37 mg/I, the differences were not significant (P = 0.11). In CAPD patients, serum lipoprotein (a) correlated with total serum cholesterol (P < 0.05) and the LDL subfraction (P < 0.05). Elevated serum lipoprotein (a) levels were associated with cerebrovascular disease in the CAPD patients (P < 0.01).
In both the transplant and dialysis populations no associations of serum lipoprotein (a) were seen with sex, duration of dialysis prior to transplantation, presence of diabetes mellitus or smoking. The present study demonstrates that an elevation in serum lipoprotein (a) concentration is very prevalent in patients on renal replacement therapy, but is not as strongly associated with the presence of vascular disease as are the total serum cholesterol, HDL and LDL cholesterol levels and the ratio of total cholesterol to HDL cholesterol.
Successful self-care home dialysis in the elderly: A single centre's experience. M. McDonald, P.D. McPhee, R.J. Walker, Department of Nephrology, Dunedin Hospital, Dunedin, New Zealand. The increasing number of older people in the population has been associated with an increased incidence of renal failure and higher acceptance rates for renal replacement therapy in New Zealand and Australia. We have analysed prospectively our unit's experience with renal replacement therapy in the 60 years and older age group since the introduction of CAPD in 1989.
There were 25 patients (21 Caucasians, 3 Maori, 1 Cambodian-16 males, 9 females) with an average age of 64.4 years (range 58.25-76.5 years at the commencement of dialysis). They made up 34% of the dialysis population and all were on self care home dialysis. At the completion of the study 17 of the 25 patients were still alive; 2 with functioning transplants, 3 on hemodialysis and 12 on CAPD. The duration on dialysis ranged from 8 to 71 months with a median of 35 months. Patient survival rates were comparable with the national average at 12 months (90% vs. 89%) and 2 years (84% vs. 80%). During the study there were 8 deaths, 6 due to cardiac causes, one due to multiple myeloma and one withdraw! from therapy. Dialysis therapy was well tolerated and technique survival rates were comparable for both hemodialysis and CAPD. At 12 months CAPD technique survival rate was 80%, 70% at 2 years and 50% at 3 years. For hemodialysis the technique survival rate was 83% at 12 months, 73% at 2 years and 36% at 3 years. The CAPD peritonitis rate was 1 in 28.5 patient months. Self care home dialysis is a viable therapeutic option with a high degree of compliance and good quality of life in the older population.
A survey of renal disease in a Northern Territory (NT) Australian This study was undertaken to investigate the relationships between the "stress hormones" corticotrophin (ACTH), vasopressin (AVP), corticotrophin releasing hormone (CRH) and cortisol, and the cytokines, interleukin-i (IL-i), interleukin-6 (IL-6) and tumour necrosis factor (TNF) in patients hospitalised with acute pyelonephritis (fever> 38°C, loin pain or tenderness, infected urine). Ten patients (7 female; age range 16-56 yr) with normal renal function were studied. Peptide hormones were measured by RIA; cortisol and cytokines by ELISA. Reference ranges were from samples donated by 40 volunteers from the electoral roll. Mean serum IL-6 and plasma AVP and CRH concentrations on admission were significantly raised above mean 0800 hr values for normal volunteers (P < 0.001), but mean plasma ACI'H and cortisol were not. Mean IL-6 and AVP were more than 2 SD5 above the mean reference range for 72 hours, although IL-6 tended to fall after 24 hr. No change in serum IL-I and TNF were observed in 3 patients.
The correlation between the IL-6 and cortisol concentrations at all sampling times and in all subjects was highly significant (P < 0.001). It has been clearly demonstrated that growth retardation associated with chronic renal failure (CRF) is significantly alleviated by administration of recombinant human growth hormone (rhGH). The mechanisms of the failure in CRF are not yet fully understood, but increased serum concentrations of insulin-like growth factor binding proteins (IGFBPs) may be involved. The current study involves the analysis of the serum of 9 boys with CRF (aged 4.6-13 years) treated with rhGH (30 IU/m2/week). We have employed fast protein liquid chromatography (FPLC) under neutral conditions in order to compare the IGF binding protein profiles at stages throughout the treatment period within the same person, and in comparison with normal age-and sex-matched children. Prior to assay of IGF-I and -II by radioimmuno-and radioreceptor assay respectively, the extraction of IGFs was achieved with the use of high performance liquid chromatography (HPLC) under acidic conditions. Serum was also assayed for IGFBP-1, IGFBP-2, and the acid-labile subunit (ALS) by radioimmunoassay. FPLC profiles demonstrated increased IGF-I binding in the 50-30 kDa binding protein region in the serum of CRF children. IGF-I and -II levels in serum rose by 160% and 40% respectively after 12 months of rhGH treatment. At the same time, IGFBP-3 concentrations rose by 97%, while IGFBP-1 fell by 35%. Levels of IGFBP-3 and ALS were strongly correlated throughout the treatment period (P < 0.01). This study showed abnormal IGFBP profiles in the serum of children with CRF. rhGH treatment resulted in greater proportional increases in IGF-I than of IGFBP-3, while IGFBP-1 levels fell, suggesting that the efficacy of rhGH in overcoming the growth retardation is, at least in part, due to a relative reduction in IGF binding capacity in serum.
Significant correlation between
Acute effect of ethanol on rat renal electrolyte transport. S.L. Carney*, A.H.B. Gillies, CD. Ray, Discipline of Medicine, University of Newcastle, NSW, 2308. The direct effect of ethanol on renal water and electrolyte transport is poorly understood despite its widespread use as a recreational drug. In particular data on the acute diuretic effect is contradictoiy and the less well known antidiuretic effect has not been evaluated. Data on electrolyte transport is sparse and also contradictory. Therefore the acute effect of increasing plasma concentrations of ethanol was evaluated in water diuretic anaesthetized rats which inhibits endogenous AVP release. Ethanol at a plasma concentration of 1.69 0.28 mmol/L produced an immediate increase in urine flow (174 11 to 189 13 and 206 12 jrL/min; P < 0.01) as well as an increase in fractional sodium excretion (0.17 0.04 to 0.28 0.05 and 0.27 0.05%; P < 0.01). There was also a brief phosphaturia. These increases in electrolyte excretion had returned no control values by 20 minutes despite a further increase in the plasma ethanol concentration. The urinary excretion of potassium, calcium and magnesium was not altered nor was glomerular filtration rate or renal plasma flow. Ethanol at a mean concentration of 3.21 mmol/L did not alter the action of a maximal concentration of AVP (75 ng/kg) on water or electrolyte transport. However, the antidiuretic effect of a submaximal concentration of AVP (7.5 ng/kg) was augmented by ethanol. These studies suggest that the ethanol induced diuresis commonly described to inhibition of AVP secretion may also be due to other intrarenal effects of ethanol, possibly acting within the proximal tubule. These results also confirm recent in vitro findings that while ethanol does not inhibit the action of a maximal concentration of AVP, it does modulate the effects of lower AVP concentrations and possibly also distal water transport in the absence of AVP. This study uses the NMR sensitivity of caesium as a congener of potassium to provide further evidence for intracellular compartmentation of tissue potassium. Following a caesium supplemented diet tissue caesium levels of 62.7 7.4, 74.2 2.9, 19.9 5.0 6.4 2.4 and 0.66 0.26 imol/g were achieved for liver, muscle, brain, erythrocytes and plasma respectively. While potassium NMR spectra of both liver and muscle show single component spectra, caesium spectra of liver at 65.60 MHz show the presence of two components the separation being up to 0.8 ppm, suggesting the presence of two pools of potassium in liver which are in slow exchange on the NMR time scale. In muscle there was a single peak. This could be due to the absence of distinct pools of potassium in slow exchange or a low proportion of all but one potassium environment. Mitochondria are a possible site for potassium to experience a different environment. NMR spectra of isolated liver mitochondria are also non Lorentzian with two peaks separated by 2.3 ppm. The two peaks seen for mitochondria are probably from the mitochondrial matrix space and the medium, as determined by shift reagent Dy(1THA)3. The distribution of caesium in the two mitochondrial compartments also changes with time. The peak attributed to matrix space changes from an initial 50% of total mitochondrial caesium to 15% after 6 h. These results add to the evidence for compartmentation of caesium, and thereby potassium, in the cell and show that NMR can be used to show dynamic changes in tissue electrolyte content.
Systemic infusion of vasoactive intestinal peptide (VIP) impairs response to a volume load. MA. Lonergan*, S. Aglibut and M.J. Field, Department of Medicine, University of Sydney, Concord Hospital NSW2139, Australia. An impaired renal excretory response to a volume load occurs in cirrhosis. As elevated systemic plasma levels of VIP, due to decreased hepatic metabolism, have been proposed to contribute to the generalised systemic vasodilation that occurs in cirrhosis and result in sodium and water retention, we conducted clearance studies in normal Sprague-Dawley rats to examine the effect of elevated plasma levels of VIP on the renal response to a volume load. Animals were studied under mactin anaesthesia. Ringer's solution was infused at 1% of body weight/h following a priming injection of 1%. After an equilibrium period, two baseline clearance periods (20 mm each) were performed, following which the Ringer's solution was increased to 4% body weight/h for four clearance periods. During the volume load VIP was infused at 0.1 nmol/100 g/hour. The Ringer's was then reduced back to 1% body weight/h for a further two clearance periods. Time Control animals (TC) received the Ringer's solution alone. Tritiated inulin and "C p-aminohippuric acid were included in the infused fluids to permit calculation of GFR, fractional electrolyte excretion rates, renal plasma flow (RPF) and filtration fraction (FF). Student's t-test was used to compare results between groups and paired t-test the delta response. Blood pressure fell significantly during the VIP infusion (15.6 3.9 mm Hg) despite the concurrent infusion of a volume load. BP did not change significantly in the TC group (2.3 4.7 mm Hg). Both GFR and RPF fell acutely with commencement of the VIP infusion but then returned to control values. FF was unchanged. Fractional (FENa) and absolute excretion (UNaV) of sodium increased significantly compared to baseline for both groups; however the response of the VIP group remained less than the TC group (UNaV VIP 5.8 1.4 and TC 9.0 0.8 tmol/min per 100 g). Flow also increased over baseline but the VIP group remained significantly less than TC. VIP therefore impairs the response to a saline load in normal animals. This is mediated in part by a fall in systemic blood pressure. These haemodynamic and renal changes are similar to those that occur in cirrhosis. These data thus support the view that VIP may be involved in the altered sodium and water homeostasis that occurs in cirrhosis.
Low protein diet on the long-term effects of warm ischaemic renal Rats, fed either normal protein (NP = 20% protein, standard pellets, Barastoc) or low protein (LP = 8% protein, an isocaloric pelleted synthetic diet), were followed for 30, 90 or 180 days. All rats survived WI and Nx with initial weight loss. Both diet groups regained weight at a similar rate. Plasma creatinine was significantly (P < 0.05) higher in LP rats from Day 8-90. Creatinine clearance was impaired in both LP and NP rats; the impairment was greater in LP rats. Compensatory renal hypertrophy (NP = 75 + 7, LP = 48 + 12% at 180 days) was also significantly impaired in LP compared to NP. Creatinine clearance per gram kidney was similar to control values in all NP and LP rats and there was no difference in interstitial fibrosis between LP and NP kidneys. After 180 days, NP rats showed increased proteinuria compared to LP rats (NP = 49 + 3, LP = 22 + 4 mg/day) but this was within normal limits (25 to 55 mg/day). Cortex and medulla had a significant leucocyte infiltration which diminished with time. After 180 days, the infiltrate was significantly lower in LP kidneys compared to NP kidneys (medulla: NP = 1500 + 30, LP = 1060 + 50 and cortex: NP = 760 + 60, LP = 520 + 50 cells/mm2). 2.4 0.03 nmol/mg protein, sa; P < 0.01). At the stage when RK tubular cell damage was evident by electron microscopy, NAG and AP activities were higher in RK than N (P < 0.001), and NAG activity was increased further by NTA-FE. Lysosomal fragility of RK and N were similar, and were decreased by NTA-FE. Mitochondrial enzyme activity was lower in RK than N, and NTA-FE had a variable and no effect Australia, 5006. Three prepubertal children with severe chronic renal failure (CRF) and short stature were treated with recombinant human growth hormone (rhGH), at 30 IU/m2/week for 2 years, each receiving a renal transplant early in the second year. Serum collected before and during therapy was analysed for insulin-like binding proteins (IGFBPs) by Western ligand (WLB) and immunoblotting techniques, and radioimmunoassay (RIA) for IGFBP-3, acid-labile subunit (ALS) and IGFBP-1. Age and sex-matched normal serum was used as control. Ligand binding was noted on WLB at 44-48, 34, 28, and 24 kDa and was identified as an IGFBP-3 doublet, IGFBP-2, IGFBP-1 and IGFBP-4 respectively by immunoblotting. A fainter protein band at 30 kDa was seen on WLB and identified as IGFBP-3 by immunoblotting. This band was also present on immunoblot in the normal controls but was not clearly seen on the WLB. IGFBP-1, not apparently present on immunoblotting in control serum, showed as a dense band in the CRF patients. This band disappeared after transplantation. IGFBP-2 was seen, on WLB, as a more intense band in CRF children prior to transplantation than in the normal controls. This band also virtually disappeared following transplantation. In the first year on rhGH treatment, mean IGFBP-3, by RIA, increased from 3.2 to 7.0 jg/ml and mean ALS from 18.4 to 41.6 ig/ml, while mean IGFBP-1 decreased slightly from 497 to 428 ng/ml. Following transplantation, mean IGFBP-3 decreased to 4.8 tg/ml, however mean ALS remained elevated at 45.2 j.g/ml. Mean IGFBP-1 fell further to 97.2 ng/ml. This study shows that rhGH treatment in CRF results in significant increases in serum levels, by RIA, of IGFBP-3 and of ALS, but not of IGFBP-1. There appear to be forms of IGFBPs present in whole serum which do not bind well to the radio-ligand during WLB, and immunoblotting may be necessary to supplement this technique for IGFBP identification. The reduction in IGFBPs following transplantation suggests correction of impaired clearance by the diseased kidney. Melbourne, Australia. TGF(31 has widespread effects on extracellular matrix (ECM) and modulates proliferation of many cell populations including mesangial cells and fibroblasts. TGFI31 stimulates its own production as well as that of other cytokines such as PDGF and IL-i. Chronic rejection (CR) is responsible for the loss of 50% of the renal grafts after the first year. The deposition of collagen and other ECM components and the proliferation of fibroblasts, resulting in damage characteristic of CR, are consistent with a possible involvement of TGFI31.
Conclusion
This study describes the expression of TGF!31 in a rat model of CR. Studies were performed on transplanted kidneys from tolerised AS recipients of DA allografts at 5 days (N = 3), 1 (N = 5) and 3 (N = 9) months post transplantation. Grafts at 1 and 3 months demonstrated progressively more severe features of CR. Controls were kidney samples from 4 normal rats (NRK), 6 isograft recipients (ISO) and 4 uninephrectomized (U) rats killed 3 months post surgery. TGFI3I gene expression was evaluated by Northern blot analysis of total RNA using a rat TGFI31 cDNA probe. RNA levels were standardised against GAPDH expression. Densitometric analysis revealed 3.8, 4.2 and 2.6 fold increases in TGF!31 expression in the CR model at 5d, 1 (P < 0.05) and 3 (P <0.01) months respectively versus NRK. Increased TGF!31 expression in CR suggests it may be involved in the development of chronic damage. Both transcripts of TGF13I mRNA (2.5 and 1.9 kb) were expressed in the CR model. The ratio of the 2.5 kb/1.9 kb transcripts was lower in the CR model [5.4 0.5 (mean sEM) and 4.6 0.6 (P < 0.05) at 1 and 3 months respectively] than in NRK (8.9
1.2). This is consistent with previous findings in infarcted rat heart suggesting that the regulation of the 1.9 kb transcript may be related to injury. TGF$31 expression in U kidneys did not differ from NRK. Surprisingly, TGFI3I expression in ISO was increased 3.9-fold (P < 0.05) versus NRK although ISO showed only minor chronic changes.
Thus increased TGF/31 expression may represent a response to transplant injury. However, there could be differences in the activation state of TGFI3I (latent or activated) in CR versus ISO, or a different relative balance of TGFI31 and other cytokines in the tissue.
Enalapril controls post-transplant erythrocytosis by suppression of erythropoietin production. KG. Wong, N. Bandler, P. G. Kerr, and R. C. Atkins, Department of Nephrology, Monash Medical Centre, Clayton Vic 3168. Eiythrocytosis is a common finding in renal transplantation. The aetiology may be multifactorial; including an increased production of Erythropoietin (EPO). Clinical studies using Angiotensin Converting Enzyme (ACE) inhibitors to treat post-transplant erythrocytosis (PTE) have predictably demonstrated its haematocrit (Hct) lowering effect but the data on changes in EPO levels are inconsistent. We therefore studied the effect of ACE inhibition on serum EPO levels and its potential benefit in controlling PTE. We treated 15 renal transplant patients (14 Mu F), mean age 51.1 11.6 (range 23-64 yrs) who had a persistent Hct of 51% or greater with Enalapril. Twelve patients had venesection before enrolling in the study. Baseline measurements of Hct, creatinine clearance and serum EPO levels were made before Enalapril therapy. Enalapril was started at 2.5 to 5 mg daily and the dose was adjusted as necessary for blood pressure control. The patients were followed at 1-2 monthly intervals with repeat Hct, creatinine clearance and serum EPO measurements. The mean Hct fell from 52.8 1.7 to 43.7 3.4 (P = 0.001) and serum EPO fell from 24.1 21.0 to 7.5 6.8 mU/mI (P = 0.018) after 2 to 6 months of Enalapril therapy. The mean blood pressure, serum potassium and creatinine clearance did not change significantly during follow up. It is concluded that Enalapri! is safe and effective in controlling PTE by suppression of EPO production.
Hyperlipidaemia and the response to simvastatin in renal transplant recipients. C.S. Ong, CA. Pollock R.J. Caterson, D.A. Waugh, J.F. Mahony, and L.S. Ibels, Department of Renal Medicine Royal North Shore Hospital, St Leonards, 2065, Australia. A seven year prospective study assessing the lipid profiles of 192 patients with functioning renal transplants, their aetiological associations and response to therapy, in particular simvastatin, was undertaken. The files of patients entered into the study were also reviewed for retrospective data regarding their lipid profile. The mean time from transplantation to last follow up was 103 4.8 (range 1-240) months. 7.8% had diabetic nephropathy as a primary diagnosis. A significant rise in serum cholesterol occurred 1-3 months after successful engraftment, stabilising over the next 3 years, at which time hypercholesterolaemia was present in 71.3% of patients. There were independent associations of serum cholesterol with prednisone dosage (P < 0.05), renal dysfunction (P < 0.05) and smoking (P < 0.05) in the early post transplant period. Those patients whose immunosuppression included cyclosporin had lower serum cholesterol levels than those receiving azathioprine and prednisone (P < 0.02). The presence of diabetes mellitus, hypertension or the form and duration of prior dialysis did not independently influence the lipid profiles. During the period of study 22 patients (11.5%) died, 54.5% due to vascular causes. Those who died a vascular death had higher serum cholesterol levels than those who died of other causes, which reached statistical significance at 3 years post transplant (7.7 0.4 vs. 5.5 03 mmol/l; P < 0.02). No differences in the HDL subfraction nor in serum triglycerides were observed in those who died of vascular causes. Cholestyramine was introduced in 30 patients, only 2 of whom continued with therapy beyond 3 months. Simvastatin was used in 43 patients, 20 of whom were receiving cyclosporin, resulting in a reduction in serum cholesterol of 16.5%, from 7.0 0.2 to 5.7 0.1 mmol/l (P < 0.001) and in serum triglycerides of 21%, from 2.9 0.4 to 2.3 0.3 mmol/l (P < 0.05). No evidence of muscle, liver or renal toxicity occurred in 15.4 0.9 months of follow up. We conclude that lipid abnormalities contribute to the high vascular mortality in renal transplant recipients and simvastatin is a safe and effective means of improving the lipid profile.
The role of eosinophils in acute renal allograft rejection. Wang Hongwei, R.S. Nanra, Anne Stein, Leanne Avis, Anna Price, and A.D. Hibberd, Nephrology, Transplantation and Anatomical Pathology Units, John Hunter Hospital, Newcastle, NSW, 2305. Tissue eosinophils (EOSs) have been previously implicated in allograft rejection and graft loss. A retrospective cohort study was undertaken to evaluate the role of EOSs in acute renal allograft rejection. Tissue EOS density was measured morphometrically. Data from 71 patients with 114 renal biopsies with acute allograft rejection were compared with that from 26 controls. The median tissue EOS density (0.4-1.1 EOSs/m2 X 106 and the median peripheral blood EOS (1.5-3.0%) in all grades of acute interstitial rejection and in acute vascular rejection were higher than that in controls (0.0 EOSs/m2 X 10, p < 0.0023, and 0.9%, P < 0.035, respectively). In all grades of rejection, 36-54% of biopsies had tissue EOS density 1 EOS4tm2 X 106, and 20-36% of patients had peripheral blood EOS 4%, compared to 0% and 4%, respectively, in controls (P < 0.000 and P 0.0245). The sensitivity, specificity and overall accuracy of predicting acute rejection with tissue EOS density i EOS/.Lm2 x 10 is 41%, 100% and 52%, and for peripheral blood EOS 4% is 23%, 96% and 40%, respectively. The median tissue EOS density in acute rejection with graft loss was 1.9
EOSs/m2 X i0 compared to 0.2 EOSs4rm2 x 10 in acute rejection without graft loss (P = 0.014), and 67% of acute rejection with graft loss had tissue EOS density 1 EOS/1.m2 X 10 compared to 28% of acute rejection without graft loss (P = 0.028). It is concluded that (1) peripheral blood EOS and increased tissue EOS density occur in up to 50% of patients with acute renal allograft rejection, (2) these may be regarded as diagnostic and prognostic markers of acute rejection, and (3) the eosinophilic response may represent a secondary or nonclassical pathway of allograft damage.
The association of acute leukaemia with the use of chlorambucil following renal transplantation. W.K W. Ho, MR. Robertson, G.J. Macdonald, LA. Charlesworth, and BA. Pussell, Dept. of Nephrology, Prince Henry Hospital and University of New South Wales, Sydney, NSW 2036 Australia. An increased incidence of neoplasms has been recognised following renal transplantation. Although these have been predominantly squamous cell carcinomas of skin, lymphomas and some mesenchymal tumours have been reported. Acute leukaemia has been reported following the successful treatment of Hodgkin's disease and breast cancer, especially with the use of alkylating agents. Because of these findings and the recent reports of the use of chiorambucil in the treatment of membranous glomerulonephritis we analysed, retrospectively, the use of different immunosuppressive agents post renal transplantation in our unit from 1.1.65 to 31.12.88. Data was obtained from the hospital records and the Australian and New Zealand Dialysis and Transplant Registry. Three hundred forty-eight patients on treatment for more than three months were assessed. Two hundred twenty-three received azathioprine alone, 90 cyclosporin A azathioprine and 35 chlorambucil. All received corticosteroids and 92 received anti-lymphocyte preparations in addition to the other agents. A total of 12 patients developed leukaemia. None of these had received immunosuppressive drugs pre-transplant and all but one was a primary renal graft. The type of leukaemia in each case was acute non-lymphocytic and all developed the leukaemia after at least 11 months of treatment. Nine patients had been treated with chlorambucil, 2 with azathioprine only and 1 with cyclosporin A azathioprine. The association between chiorambucil exposure and development of leukaemia was highly significant ( = 52.93; P < 0.0001). In addition, within the chlorambucil treated patients there was a relationship between total dose of chlorambucil and development of leukaemia (mean 5537 mg versus 3138 mg; t = -2.59; P < 0.02). Of 71 patients who received anti-thymocyte preparations, 2 developed leukaemia and these 2 had also received chiorambucil. None of 21 patients treated with OKT3 developed leukaemia. The time from transplant to diagnosis of leukaemia ranged from 11-164 months (median 70) and from diagnosis to death was 8-259 days (148) . All patients died from the leukaemia. This highly significant association between the use of chlorambucil and subsequent development of acute leukaemia suggests caution in the use of this agent in renal transplantation and may also have implications for the recent interest in its use to treat diseases such as membranous glomerulonephritis. possibly by modulating the intrarenal renin angiotensin system. We studied the effects of similar blood pressure control using enalapril (10 mg/kg/day) or verapamil (13 mg/kg/day) on glomerular angiotensin II receptors, glomerular protein, creatinine clearance and proteinuria in the spontaneously hypertensive rat (SHR) three months after induction of diabetes by streptozotocin. Blood glucose was maintained at 8-10 mmol/l by daily insulin injection and blood pressure at 105-120 mm Hg systolic in both groups. Creatinine clearance was lower in enalapril (0.46 0.05 mi/mm; P < 0.001) and verapamil (0.55 0.06 ml/min; P < 0.03) groups than control (0.77 0.06 mI/mm) while proteinuria was lower in the enalapril group (E: 5.6 0.79, C: 11.4 1.50, V: 13.2 1.47 mg/24 hr; E vs. C: P < 0.0025, E vs. V: P < 0.001). Glomerular Ang II receptors were decreased in the verapamil group (1804 202 fmoles/mg protein) compared with enalapril (3079 149, P < 0.001) and control (2763 345, P < 0.01). Glomerular protein was least in the enalapril group (48 3.1 ng/glomerulus) and greatest in the verapamil group (84 9.8 ng/ glomerulus, P < 0.0025). We conclude that both antihypertensive regimes are equally effective in lowering blood pressure and preventing hyperfiltration. However, treatment with ACE inhibitors significantly reduces proteinuria. In addition, by reducing Ang II stimulated glomerular protein synthesis they may play a role in preventing glomerular sclerosis.
The effect of intravenous ouabain on pressor responsiveness in healthy volunteers. G.B. Pidgeon, A.M. Richards, M.G. Nicholls, R.R. Bailey, KL. Lynn, L.K Lewis, and T.G. Yandle, Departments of Nephrology, Cardiology and Endocrinology, Christchurch Hospital, Christchurch, New Zealand. To assess the effects of ouabain on pressor and vasoactive hormone responsiveness, 10 healthy volunteers were pre-treated with ouabain (0.5 mg iv. 42 and 18 hrs before study) or placebo, prior to pressor challenge with angiotensin II (Ang II) (2, 4 and 8 ng/kg/min for 30 minutes per dose) and noradrenaline (NA) (5, 15 and 45 ng/kg/min for 15 minutes per dose) in single-blind, randomised, placebo-controlled, cross-over studies. Blood pressure and heart rate (HR) were recorded manually at 15-mm (Ang II) and 5-mm (NA) intervals. Holter ECG monitoring was performed.
Vasoactive hormones were measured at baseline and during infusions, There were no differences at baseline between the two study days regarding plasma electrolytes, creatinine, mean arterial pressure (MAP) or HR. Baseline pulse pressure, however, was significantly greater following ouabain (47 4 mm Hg vs. 41 1 mm Hg) [mean SCM] (P < 0.05).
The mean maximum increments in MAP during Mg II and NA infusions were 17.5 1.1 and 10.5 1.3mm Hg respectively following ouabain, and 19.2 1.3 and 10.4 1.5 mm Hg following placebo (NS). The mean HR was lower during both infusion periods on the ouabain study day compared to control (P < 0.05). Baroreceptor reflex sensitivity was unchanged. Baseline plasma levels of Ang II, aldosterone, plasma renin activity, atrial and brain natriuretic peptide, cyclic GMP, NA and adrenaline, and achieved levels during the two infusions, were similar on the two study days. We conclude that short-term ouabain administration does not alter pressor responsiveness or plasma levels of vasoactive hormones in healthy volunteers. of Melbourne, Parkville, Victoria, 3052. Three receptors for the atrial natriuretic peptide family have been identified. The GC-B receptor is a membrane bound guanylate cyclase receptor which appears to have C-type natriuretic peptide (CNP) as its natural ligand. CNP was initially thought to be confined to the central nervous system, but mRNA for both CNP and GC-B has recently been identified in most body tissues, where they are thought to be possibly involved in a vascular autocrine or paracrine system. As a CNP bolus had been reported to cause an antinatriuresis, without change in blood pressur&, we wished to see if mRNA levels for the GC-B receptor varied with sodium status. A 461 bp fragment of eDNA for the ovine GC-B receptor was cloned from ovine pituitary RNA using reverse transcriptase-PCR. There was 90% nucleotide sequence identity to the human GC-B receptor and 97% similarity at the amino acid level. The eDNA fragment was used as a probe for northern analysis of mRNA isolated separately from renal cortex and medulla of 6 Na loaded, 6 Na depleted and 4 control sheep. Levels of mRNA for the receptors were quantitated using laser densitometry and standardised to 13-actin expression. The level of mRNA for the GC-B receptor in the renal cortex was significantly higher in sodium depleted animals (1.57 0.17, mean SCM) than in sodium loaded (0.86 0.12) or control (0.84 0.18) animals (P <0.05). To investigate the role of CNP in renal function in sheep, CNP was infused into the renal artery of 4 uninephrectomised, conscious, sodium replete merino ewes at a rate of 185 pg/hr for one hour. MAP fell from 80 3 mm Hg during the control period to 72 2 mm Hg in the 15 mm period following the infusion (P < 0.01). There was no significant effect on GFR, ERPF, urine flow rate, Na, K or Ca excretion, although the animals responded to ANP (50 pg/hr) with the expected increase in Na excretion (from 153 33 .tmol/min to a maximum of 456 43 imol/min).
In summary, we have shown that mRNA for the GC-B receptor is present in sheep kidney, and levels increase approximately two-fold with Na depletion. However we have been unable to detect any effect of CNP, its proposed natural ligand, on renal function. the presence of phospholipids for activity. To confirm that glomerular PCA was due to TF, a monoclonal anti-rabbit TF antibody was prepared that totally inhibited glomerular PCA. TF expression was assessed at days 1,4,7, and 12 in a preimmunised rabbit model of anti-GBM crescentic GN and in normal rabbits. TF functional activity was determined in a one stage prothrombin assay. TF molecular weight was determined by Western blotting and subsequent immunodetection with a monoclonal antibody to rabbit TF. TF mRNA was assessed by Northern blotting and in situ hybridization with a cDNA to rabbit TF. TF activity was upregulated at day 1 (208 70 an (P < 0.05)) cf normal (40 1670 au) and remained elevated throughout. Glomerular TF antigen was not increased until day 4 (2.43 0.09 au (P < 0.045)) ci normal (1.69 0.24 au). Rabbit glomerular TF antigen exhibited a higher molecular weight (Mw) than standard rabbit brain TF. The Mw of glomerular TF on days 4, 7, and 12 of this disease (the days associated with prominent glomerular macrophage infiltration) showed higher Mw bands to those seen in normal glomeruli. The Mw of glomerular TF on these days corresponds to that of TF expressed by activated macrophages. The variation in TF Mw on different days and between organs was shown to be due to variable glycosylation. TF mRNA was demonstrated to be intraglomerular by in situ hybridisation. Glomerular TF mRNA was not significantly increased until day 4 (169.8 18.3 AU (P < 0.044)) cf normal (100 12.1 AU). In this model of GN increased glomerular PCA is due to TF; increased TF functional activity precedes increases in TF antigen and mRNA; and the higher Mw of TF at day 4 is associated with macrophage influx. This suggests macrophages are the most likely source of this Mw TF. The dissociation of the increase in TF functional activity and antigen expression may be due to a change in the TF phospholipid association and/or the presence of inhibitors. Alteration in TF glycosylation may in turn alter its avidity for inhibitors.
Risk factors for acute pyelonephritis in preschool children. J.C. Craig L.P. Roy, and J.F. Knigh4 Department of Nephrology, Royal Alexandra Hospitalfor Children, Sydney, NSW, 2050. To determine the epidemiology, microbiology, and natural history of the first symptomatic urinary tract infection (UTI) in preschool children with no known predisposing condition, a prospective study of all eligible children presenting acutely to this hospital has been established, and the frequency of acute pyelonephritis (APN) and risk factors for this precursor of renal scarring have been determined. To date, 125 children have been identified, primarily by analysis of all urine samples sent to the microbiology department for microscopy and culture. Patients were reviewed whilst in the acute phase of the illness and all relevant clinical and microbiologic details were recorded. The diagnosis of APN was made by dimercaptosuccinic acid scan (DMSA). Abnormalities in the DMSA scan were graded from 1-4 (grade 1: 1 or 2 focal defects, grade 2: 3 or more focal defects, grade 3: diffuse parenchymal abnormality >10% differential function, grade 4: 10% differential function), with the DMSA score defined as the sum of the score of each of the 2 renal units. Of the 125 children with a proven UTI presenting to this hospital, 121 (97%) have had a DMSA scan from 1-25 days after diagnosis (mean 7.7 days, sn 4.4 days). Thirty-four percent had scan evidence of APN (41 patients, 52 renal units). One hundred twenty-two patients (98%) had a renal ultrasound (USS) examination.
Vesicoureteric reflux (VUR) was present in 31% of 106 patients in whom a micturating cystourethrogram (MCU) has been performed. VUR was detected in only 59% of children with APN. The USS correctly detected APN in 20%. All variables of epidemiology, clinical presentation, microbiology, ultrasound and MCU results were analysed as possible risk factors for acute pyelonephritis (abnormal DMSA scan) using linear regression. Only a history of previous unexplained fever (relative risk of 4.3 (95% CI 1.2-15.4, P = 0.027) and VUR (relative risk of 5.6 (95% CI 2.2-15.4, P = 0.0001) were found to be significant predictors of APN. These same variables were analysed by logistic regression to determine independent predictors of the DMSA score. VUR, intrarenal reflux (IRR), and calyceal dilatation on ultrasound were all found to be highly predictive of the DMSA score. We conclude that a history of unexplained fever and VUR predict for APN, and VUR, IRR and calyceal dilatation predict for the severity of APN. However, the sensitivity of the MCU in detecting preschool children with APN is only 59%, therefore this test alone, or in combination with the USS, does not detect acute parenchymal defects in 40% who may be at risk of permanent scarring.
Peritoneal dialysis solutions (PDS) inhibit human mesothelial cell biosynthesis in vitro. S.D. Bird, F.M. Munro, and R.J. Walker, Medicine Dept., Otago Medical School, Dunedin, NZ. Peritoneal dialysis solutions (PDS) utilise high glucose concentrations (76-214 mM) for ultrafiltration. Recent studies have suggested that PDS may be cytotoxic to mesothelial cells. The initial peritoneal mesothelial cell (PMC) response to exposure to PDS has not been well defined. Aims: to define the biosynthetic response of human PMCs to PDS compared to an epithelial cell line (LLC-PK). Human PMCs were obtained from omentum by enzymatic digestion and grown in DME/F-12 media with 10% FCS. Cells were used at passage 2. Confluent cells in 24 well plates were exposed to KR buffer (glucose 5.5mM), 1.5% (76mM), 2.5% (126mM), 4.25% (214 mM) PDS for 2-8 hours. DNA and protein synthesis was measured by 3H-thymidine (3HT) and 3H-leucine (3HL) incorporation (cpm/mg protein). Cell viability was measured by trypan blue exclusion. Results are mean SCM N = 10-20. *P < 0.05. were much slower to recover following re-exposure to normal culture media. This is most likely an acute response to the high glucose concentrations. Experiments are currently underway to exclude pH or osmotic effects. This would suggest alternative agents to glucose in PDS need to be found.
Circulating renotropic factors and epithelial transport. C.A. Polloc/ç M.S. Nobes, A.Z. Gyoy, P. T Heng and M.J. Field, Department of Medicine, University of Sydney, Royal North Shore Hospital, St Leonards, 2065, Australia. It has been postulated that circulating growth factors play a role in the development of renal hypertrophy. In order to investigate the effect of these factors on glomerular filtration and epithelial transport, micropuncture experiments were performed on normal 6-7 week old Sprague Dawley rats infused with 20% plasma derived from rats in whom nephrectomy had been performed 3 days previously; N = 4. Animals infused with plasma from rats which had undergone sham nephrectomy served as controls; N = 4. When animals infused with plasma from nephrectomised animals (NxP) were compared with those infused with control plasma (CP), the former had a higher tubular fluid flow rate measured at both the late proximal (LP) (26.7 1.6 vs. 18.3 1.4 nI/mm; P < 0.0005) and early distal (ED) (14.9 1.0 vs. 7.8 1.0 nI/mm; P < 0.0001) site, which was reflected in the final urine flow rate (16.1 3.4 vs. 5.1 0.8 jl/min; P < 0.005). The single nephron glomerular filtration rate (SNGFR) was higher as determined at the LP (45.8 2.8 vs. 35.7 2.3 nl/min; P < 0.01) and ED (34.5 2.5 vs. 28.1 1.8 nI/mm; P = 0.05) site. However, this increase was not reflected in the whole kidney GFR (1.04 0.06 vs. 0.89 0.06 mls/min/100 g; P = 0.07), suggestive of a preferential increase in filtration in the outer cortical nephrons. Tubular Na transport was higher in the animals infused with NxP, as evidenced by a decrease in the fractional delivery of Na at the early distal site (4.5 0.4 vs. 6.5 0.4; P < 0.02). However, in the final urine there was a significant increase in the fractional sodium excretion in animals infused with Nx plasma (0.67 0.14 vs. 0.29 0.09%; P < 0.05) indicating that natriuresis and probably diuresis was a result of inhibition of Na and water transport in the late distal tubule and collecting duct. In conclusion these experiments demonstrate that circulating factors induced by a reduction in renal mass significantly alter glomerular filtration and tubular Na transport. Although the present experiments do not define the nature of these factors, it is likely that they play a role in the subsequent development of compensatory renal hypertrophy.
Detection of hydroxyl radicals following ischaemia and reperfusion in isolated rat kidneys. M Kadkhodaee, Z.H. Endre, R.A. Towner, and M Cross, Department of Medicine, University of Queensland, Royal Brisbane Hospital, Qld 4029. The role of oxygen derived free radicals in acute renal failure remains controversial. In order to quantitate hydroxyl radical generation in vitro in isolated rat kidneys during hypoxia and during reperfusion following ischaemia, salicylate was used as a chemical trap to react with hydroxyl radicals to produce 2,5-dihydroxybenzoic acid (DHBA) which could be detected by HPLC combined with electrochemical detection (ED). Right kidneys from male Wistar rats perfused with Krebs-Henseleit buffer (KHB) with 6.7% albumin. Perfusion pressure, flow and oxygen tension were continuously monitored. Function was monitored from the inulin clearance and sodium and potassium excretion. Five groups (each N = 5) were studied: group 1 (normal control), perfused for 75 mm; group 2 (salicylate control), supplemented with 0.5 mi's salicylate; group 3 (ischaemia), salicylate plus ischaemia induced for 15 mm followed by 15 mm reperfusion; group 4 (DMTU-ischaemia), 15 mM DMTU plus salicylate, before induction of ischaemia followed by reperfusion; group 5 (hypoxia), salicylate followed by 15 mm of hypoxic perfusion. Under normoxic conditions in salicylate control kidneys (group 2), peaks corresponding to the hydroxyl radical were detected as 2,5-DHBA. During ischaemia and reperfusion (group 3) there was more than a two fold increase in production of hydroxyl radical (P < 0.001). Adding 15 mM DMTU before ischaemia (group 4) prevented the increase in 2,5-DHBA. Induction of 15 mm of hypoxia (without normoxic reperfusion) impaired kidney function predictably (group 5) but did not increase 2,5-DHBA. This supports the recent observation that DMTU and DMSO protect against hypoxic injuly by a mechanism independent of the binding of free radicals. The increase of 2,5-DHBA in ischaemic-reperfused kidneys, indicates hydroxyl radical formation which is supported by the observation that pretreatment with DMTU prevented any increase in 2,5-DHBA. This is the first observation in vitro or in vivo of specific hydroxyl radical generation following ischaemia-reperfusion in the intact kidney. Microscope Unit, University of Sydney, Royal North Shore Hospital St Leonards, NSW, 2065. The renal toxicity of AMB clinically manifests largely as distal tubular injury, with K wasting, renal tubular acidosis and a reduction in GFR. The defect is presumed to be due to an increase in permeability of Na, K and H ions in the tubular epithelium. As this toxicity has been shown in vitro to uniformly affect the nephron, it is surprising that more marked proximal tubular dysfunction is not observed. The following experiments, on male Wistar rats, were designed to assess using electron microprobe analysis (EMPX), the alterations in intracellular electrolyte concentrations in proximal tubular cells as a result of AMB treatment.
Five animals were prepared as for micropuncture experiments and infused with modified Ringers solution at 1.2 ml/100 g/hr. After equilibration, two 30 minute clearance collections were done. AMB was then infused at a rate of 1 mg/kg/hr and after equilibration 2 further clearance collections were made. At the conclusion of the clearance study isotonic RbCI was infused at 0.5 mmol/kg over 30 sees, as a further marker of K transport, and the kidney immediately removed. Controls were animals infused with Ringers solution or AMB buffer alone. Clearance data confirmed a drop in GFR in the AMB treated rats compared to control (0.69 0.11 vs. 1.27 0.08; P < 0.001). However, no difference in the urine flow or fractional excretion of Na and K was evident. Measurement of intracellular electrolytes of PT cells in mmol/kg wet weight by EMP analysis demonstrated no difference in Na (16.1 0.6 vs. 17.2 0.5) or K (129.7 2.1 vs. 131.3 2.0). However, a significant reduction in Cl occurred (12.7 0.4 vs. 14.1 0.4; P < 0.05). Intracellular Rb accumulation was significantly reduced in the AMB treated animals (3,9 0.4 vs. 6,6 0.4; P < 0.0001) suggestive of a reduction in basolateral Na-K ATPase activity. These results do not support the tenet that AMB causes a generalised increase in epithelial cell membrane permeability, nor direct cellular toxicity in the doses studied. Rather they suggest that a primary reduction in GFR results in a load-dependent decrease in proximal tubular Na transport.
Alterations in plasma ANP, BNP and cardiac volumes with changes in intravascular volume in chronic renal failure. J.M. Corboy, R.J. Walker, M. Simmonds, G. T. Wilkins, A.M. Richards, and E.A. Espiner, Medicine Dept., University of Otago Medical Schoo4 Dunedin, NZ. Atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) levels are elevated in conditions of fluid overload including chronic renal failure (CRF). This study was designed to investigate the changes in plasma ANP and BNP with changes in atrial and ventricular volumes following alterations in intravascular volume during hemodialysis. Eight patients (6 males) with chronic renal failure (CRF) on haemodialysis, who were normotensive with no heart disease were studied. Two phases in the study. 1. Ultrafiltration (UF) (3% body weight) over 2 hours. 2. Volume repletion over 2 hours plus an additional 0.51 saline. Weight (bed scales), blood pressure, heart rate were recorded and venous samples (electrolytes and hormones) were measured every 30 mins. Two-dimensional echocardiography was performed at 0, 120, 240, 270 mins and chamber volumes calculated, Results: Changes in plasma ANP during UF correlated significantly with changes in LAy (r = 0.64). There was no significant correlation between BNP and cardiac volumes during UF or volume replacement. Discussion. Baseline levels of ANP and BNP were elevated above normal with a significant reduction in plasma ANP and BNP (minor) following UF. The exaggerated release of ANP during volume repletion was not paralleled by changes in BNP levels. Changes in BNP levels were small with no correlation with atrial or ventricular volumes. This would suggest that in CRF, ANP release is a more important factor in regulating acute changes in intravascular volume. In CRF and normal myocardial function, BNP appears to have only a minimal role in acute changes in intravascular volume, despite elevate basal levels.
In vivo regional image-guided 1H-NMR spectroscopy of rat kidney. R.A. Towner, Z.H Endre, S. Wilson, and D. Doddrell, The University of Queensland, Royal Brisbane Hospital and Centre for Magnetic Resonance, Brisbane, QId. 4072 Australia. We present the first noninvasive study of in vivo cortical and medullary image-guided proton NMR spectroscopy in rat kidney. This technique was also used to monitor biochemical changes during and after in vivo ischaemia-reperfusion injury. Image-guided, microvolume, high resolution localized 'H-NMR spectra were obtained in vivo at 4.2 T in kidneys of 150 g Wistar rats from 14-20 j.rl volumes (2.2 X 2.2 x 2.2 mm3 to 2.7 X 2.7 X 2.7 mm3) using the VOSY pulse sequence with CHESS water suppression, an actively decoupled resonator/surface coil assembly, a high strength (30 Gauss/cm) gradient set, and respiratory gating. Spatial coordinates for the localized 1H-NMR spectra were obtained from transverse 1H-NMR images (spin echo; TRTI'E 18/800 ms) of anaesthetized rats (1.5% Isoflurane). The obtained microvolume spectra allowed non-invasive in vivo differentiation of biochemical information between cortex and medulla. The main biochemical differences detected were much higher amounts of osmolytes, such as the trimethylamines (TMA5; e.g., betaine), inositol and sorbitol in the renal medulla than in the renal cortex. The same sequences were used to monitor renal medulla before, during and after ischaemia-reperfusion. The right renal artery was surgically exposed and fitted with an adjustable mechanical occluder. Renal medullary 'H-NMR spectra showed that during 30 mm ischaemia, lactate levels increased whereas sorbitol and TMAs decreased. After reperfusion sorbitol and TMA levels increased within 15-30 mm, and lactate decreased to pre-ischaemic levels over 1-2 hours. This technique appears to be suitable for differentiation of in vivo biochemical information between the renal cortex and medulla, and for assessment of in vivo renal ischaemia-reperfusion injuiy.
Mechanism of tubular uptake of filtered iron in rat remnant kidney (RK) . B.J. Nankivell, Y.C. Tay, R.A. Boadle, J. Chen, and D.C.H. Harris, Dept. Renal Medicine and EM Unit, Westmead Hospital, NSW 2145. Iron accumulates within proximal tubular lysosomes in human and experimental chronic renal failure. The mechanism of accumulation has not been defined. The effect of iron-transferrin dissociation on tubular iron uptake was determined in RK (N = 35) and sham-operated controls (SO, N = 16) fed a NaHCO3-or NaCI-supplemented diet for 8 wks. NaCI-fed RK rats had increased systolic blood pressure, final serum creatinine and decreased urinary pH. The substantial accumulation of iron, as demonstrated by energy dispersive X-ray analysis (EDS) in RK (P < 0.01 vs. SO), was not influenced by urinary pH, suggesting that dissociation of iron from transferrin did not occur in the acidic tubular-lumen. The filtered protein marker, horse-radish peroxidase (HRP, 6.25 mgJlOO g BW), was also administered to RK and controls. Uptake of protein and iron by individual tubules was determined by EM histochemistry and EDS, on tissue fixed 15 and 60 minutes after HRP injection. Iron was present with HRP in apical lysosomes. After 15 minutes, HRP uptake correlated with numbers of iron-containing lysosomes (r = 0.65, P < 0.01). At one hour, secondary lysosomes (HRP-negative) contained less iron than recently reabsorbed, HRP-positive lysosomes (P < 0.01), consistent with release of lysosomal iron. Electron-dense focal accumulations of iron were demonstrated in tubular cytoplasm (but not nucleus) at high-magnification, by EDS. These data demonstrate in RK that filtered iron-transferrin can be reabsorbed intact across the brush-border membrane into tubular lysosomes along with bulk protein uptake, followed by release of iron and overload of cytoplasmic stores.
Effect of cyclosporin on macrophage infiltration and cellular proliferation in the Thy-i.! model. Mary Polihronis, Brendan F. Murphy, and David A. Power, Dept. Nephrology and Clinical Immunology, St. VIncent's Hospital, VIC, 3065. Accumulation of glomerular extracellular matrix and proliferation of mesangial cells are important features of glomerulonephritis (GN) that progresses to end-stage renal disease. A model of mesangial proliferative GN can be induced with an antibody directed to the Thy-1.1 antigen on mesangial cells. Chemokines such as monocyte chemotactic protein-i (MCP-1) and cytokines including platelet-derived growth factor (PDGF) and transforming growth factor-13 (TGF-3) appear to be important in the pathogenesis of this model. In this study, therefore, we attempted to modify the Thy 1.1 model with Cyclosporin A, a cytokine inhibitor. Glomerulonephritis was induced in two groups of rats by a single intravenous injection of anti-thymocyte serum. One group of animals was treated with CsA 10 mg/kg daily, the other served as a control. The rats were sacrificed at various time points. Histologic examination of kidneys biopsies revealed significant differences between the control and CsA treated rats in the extent of macrophage infiltration and mesangial cell proliferation. At day 3 there was a significantly (P < 0.01) greater influx of ED-i positive cells (6.47 0.61) in untreated rats compared with CsA-treated animals (2.33 0.61). Expression of a-smooth muscle actin, which has been associated with mesangial cell proliferation in this model, was also reduced in rats treated with CsA but there was no change in the number of cells expressing PCNA, a marker of proliferating cells. These results suggest that cyclosporin reduces the signals leading to macrophage infiltration within the mesangium in the Thy 1.1 model. Secondly, there is no direct relationship between mesangial cell proliferation and a-smooth muscle expression, as has previously been reported.
Renal hypertrophy in two rat models of cirrhosis. MA. Lonergan, S. Aglibut, and M.J. Field, Department of Medicine, University of Sydney, Concord Hospital, NSW 2139, Australia. Avid proximal tubular sodium retention occurs in cirrhosis. Renal hypertrophy occurs in other circumstances of increased tubular transport. During studies of possible mediators of the altered sodium and water homeostasis that occurs in cirrhosis, we measured rat kidney weights to examine if alterations in renal mass were seen in these models. Two models of cirrhosis were utilised, that of carbon tetrachloride-induced cirrhosis (Cd4), and bile duct ligation and resection (CBDL). Controls for the CCI4 model consisted of rats receiving phenobarbitone alone and for the CBDL model, sham operated rats.
Clearance studies were performed under mactin anaesthesia after 16 weeks for CC!4 and 4-5 weeks for CBDL, following which animals were bled for biochemical studies. Following exsanguination, the capsule of each kidney was stripped and the renal pedicle cut flush with the hilum. The kidneys were patted dry and weighed. In both models, the kidney weights, both absolute and relative (per 100 g of bodyweight) were significantly greater in the cirrhotic rats than in the controls (P < 0.001).
In the CC!4 model: the absolute weight of the right kidney of the Control rats (N = 29) was 1.48 0.03 and of the CC!4 (N = 34) 1.66 0.04 grams; relative weight of the Control was 0.306 0.004 and CC!4 0.409 0.013. In the CBDL model: the absolute weight of the right kidney of the Sham rats (N = 20) was 1.38 0.03 and of the CBDL (N 27) 1.52 0.03; relative weight of the Shams was 0.33 0.009 and of the CBDL 0.46 0.013. The increased weight of the kidneys is consistent with renal hypertrophy occurring in response to the avid proximal tubular sodium reabsorption that occurs in cirrhosis. Although the changes in renal function that occur in cirrhosis are due primarily to hormonal effects resulting from the altered haemodynamics in this condition, the present results suggest that there are also intrinsic (structural) changes induced in the kidney that may contribute further to the altered tubular handling of salt and water. These findings justify further studies into the morphological basis of the hypertrophy, and into the possible mediating factors, such as hepatocyte growth factor.
Mast cells (MC) and type VIII collagen in human diabetic nephropathy (DN). B. Ruger, R. Dunbar, Q. Hasan, N. Greenhill, H. Sawada, and T.J. Neale, Dept. of Medicine, Wellington School of Medicine, and Yokohama City University, School of Medicine, Yokohama, Japan. Human MC are increasingly associated with angiogenesis, chronic inflammation and fibrosis but are not known to produce extra cellular matrix (ECM) components. Type VIII collagen is a non-fibrillar short chain collagen (also associated with angiogenesis) that forms a molecular bridge connecting ECM components. MC were identified in a number of tissues with monoclonal antibodies specific for human tryptase, chymase, and c-kit and histochemically with berberine sulphate, safranin and alcian blue. Many MC expressed type VIII collagen by immunohistochemistry using antibody specific for the a-i chain. MC did not express the interstitial collagens I, III and V and pretreatment with collagenase abrogated type VIII collagen staining but did not prevent staining for tryptase. We examined the contribution of MC and type VIII collagen to the fibrosis occurring in DN. MC were prominent in the interstitium in DN (N = 20) and were located particularly perivascularly. Periglomerular fibres in DN stained intensely for type VIII collagen. There was a correlation between the proportion of MCTC cells and the percentage MC positive for type VIII collagen in DN.
RT-PCR identified the mRNA for type VIII collagen in kidney tissue. Digoxigenin-labelled anti-sense probes specific for type VIII collagen mRNA proved by in situ hybridisation that MC in the kidney produce type VIII collagen. Sense probe and RNase pretreatment controls were negative indicating specificity. MC proliferation and type VIII collagen production in situ may be early events in fibrosis, that are later assisted or completed by fibroblasts and their interstitial fibrillar collagen products. Our finding that type VIII collagen is produced by human MC in fibrotic tissues, particularly DN, provides the first evidence of a synthetic role for MC in the construction of connective tissue in vivo.
Collagen type HI glomerulopathy: Extension beyond the glomerulus. J.P. Dowling, I.K Forbes, and S. T Chou, Departments of Anatomical Pathology and Nephrology, Royal Melbourne Hospital, Parkville 3050, Victoria, and Pathology Repatriation Hospital, Heidelberg. An unusual form of renal disease characterized by the mesangial, glomerular capillary loop and, perhaps, tubular basement membrane accumulation of material shown by immunohistochemistiy to Consist mostly of collagen type III has been increasingly recognized in both adults and children. The ultrastructural features are similar to those of the nail-patella syndrome (N-PS). We present a recent example of this rare lesion which developed in a 51 year old female of mid-European origin who for several years prior to the development of microscopic haematuria and mild proteinuria (0.6 gm/ day) had been treated for hypertension, hypercholesterolaemia and peripheral vascular disease involving carotid and leg vessels. An intravenous pyelogram was normal. Antinuclear antibody titre was 1:150 and erythrocyte sedimentation rate 70 mm/hr. Serum creatinine at the time of renal biopsy was 0.10 mMo!/l and she was receiving Enalapril. Renal biopsy revealed striking mesangial acellular nodular expansion and capillary wall thickening with mild glomerular hypercellularity and mild tubulointerstitial damage with patchy thickening of tubular basement membranes, all due to the accumulation of lightly eosinohilic amorphous material. Immunohistochemistry showed irregular light to moderate 1gM staining of capillary loops and mesangia and the amorphous material stained strongly in all areas with an anti-collagen type HI antibody on streptavidin-biotin immunohistochemistry. Severe intracranial disease and cardiac failure with cardiac ariythmias developed and the patient died 20 months after renal biopsy. Autopsy findings revealed little if any progression in renal deposition of collagen III, atherosclerosis of aorta with involvement of coronary, carotid and renal ostia and evidence of myocardial and cerebral ischaemic damage. The renal lesion which may be part of a generalized disturbance of collagen metabolism appears distinct from NPS and is suggested by Gubler et al to have autosomal recessive as opposed to the autosomal dominant inheritance in N-PS. This is the first report to emphasize involvement of tubulointerstitial tissues in the process.
1. GUBLER MC ET AL.: Pediatr. NephroL 1993, 7:354-360 Modulation of cytokine and fibronectin expression in an animal model of focal glomerulosclerosis by a low protein diet. Brigitte Schiller and John Moran, Dept. of Nephrology, Rush Presbyterian Medical Center, Chicago, IL, USA; Renal Division, Baxter Healthcare, McGaw Park, IL, USA. We investigated cytokine expression in the puromycin aminonucleoside (PAN) model of focal glomerulosclerosis (FGS) in two groups of rats fed either a 24% (normal) or 6% (low) protein diet followed for 28 days.
Cytokine expression was evaluated by Northern blot of pooled RNA from whole kidneys (3-5/group) hybridized with IL-i j3, TNF-n, TGF-J3, MCP-1 and fibronectin. Both PAN groups showed significant proteinuria from day 5, with a peak on day 10: (Mean SD) 679 37 (24%) vs. 417 63 mg/24 hours (6%). FOS was significantly less in the 6% group (7.5 1.2 vs. 20.7 3% of glomeruli, P < 0.05). TGF-3 expression was found to be only slightly altered within the first 7 days in both PAN groups. However on day 10 a marked increase in both groups (2-fold in 6% group, 3-fold in 24% group) was found, which progressively increased until day 28 (5-fold in 24% group, 2.5-fold in 6% group). MCP-1 showed in the 6% group an immediate 6-fold increase on day 5, whereas the 24% results remained similar to control values. On day 28 we found a 3-fold increase in the 6% protein group, which was again lower in the 24% group at this time (2-fold). IL-ip or TNF-a expression was not detected. Fibronectin expression was more than 6-fold increased on day 28 in the PAN 24% group, whereas the 6% group was close to control levels. Conclusion: A low protein diet modulates the expression of MCP-1, TGF-/3 and fibronectin in kidneys developing glomeruloscierosis after PAN injection. This altered cytokine expression may explain the decreased FGS in rats on the low protein diet.
Focal glomerulosclerosis in the remnant kidney model: An inflammatory disease mediated by cytokines. Brigitte Schiller, Michael DeLeo, Emily Warren, and John Moran, Dept. of Nephrology, Rush Presbyterian Medical Center, Chicago, IL, USA; Renal Division, Baxter Healthcare, McGaw Park, IL, USA. We investigated cytokine expression in 5/6 nephrectomized rats fed a normal (24%) or low (6%) protein diet and compared to sham operated rats on the same diets. The rats on 6% protein had less proteinuria than the rats on 24% (Mean SEM: 2 weeks, 45.1 1.07 vs. 126.7 3.53; 4 weeks, 36,9 4.51 vs. 175.8 34.41 mg/24 h) and significantly less focal glomerulosclerosis (FGS) (17.4 4.4 vs. 27.4 8.8% of glomeruli at 7 weeks). Cytokine expression was evaluated by Northern blot of total pooled RNA extracted from whole kidneys (N = 3-5). Monocyte chemoattractant protein (MCP-1) was increased in both groups after 2 weeks to 3 times control levels. However, after 4 weeks MCP-1 expression decreased in rats on 6% protein (1.5 times control) and reached control levels after 7 weeks. In contrast, in the 24% group it increased further after 4 weeks (5.6 times control) and was still twofold higher after 7 weeks. Transforming growth factor-f3 (TGF-/3) was found to be modestly upregulated in both groups at 2, 4 and 7 weeks to between 120 and 160%. IL-i j3 and TNF-a were not detected. Conclusion: In this model an initial "mechanical" injury results in a sustained inflammatory response within the kidney. MCP-i and TGF-j3 may play a role in the pathogenesis of FGS in this model. A low protein diet modulates the expression of MCP-1 and improves the morphological outcome after renal ablation, suggesting an alternative mechanism to the "hyperfiltration" hypothesis.
Evidence for pre-eclampsia in a baboon pregnancy with twins. A. Hennessy, A.G. Gillin, D.M. Painter, P.J. Ki,win, and J.S. Horvath, Departments of Renal Medicine and Anatomical Pathology, Royal Prince Alfred Hospital Camperdown, 2050. Preeclampsia (PE) is a syndrome of hypertension, oedema and proteinuria in pregnancy accompanied by hepatic damage if severe, which resolves after delivery. A pathognomonic renal lesion characterised by endothelial swelling, mesangial expansion, double contouring of the basement membrane and fibrin deposits has been described. This condition is almost exclusively a human disease and risk factors for its development include molar pregnancy, multiple pregnancy and primiparity. Primates rarely develop PE spontaneously. This paper describes the renal biopsy findings in a case of twinning in a baboon (Papio hamad,yas) that had an otherwise symptomatically normal pregnancy. The aim of this study was to demonstrate the similarity of pathological changes in primate PE with those seen in human pregnancy. Methods. The animal had a twin pregnancy, duration 180 days (RR 182 5 days), At 173 days an open wedge renal biopsy was performed and then repeated at five months post-partum (PP). This animal was studied as part of a wider study to examine the effect of uteroplacental ischaemia on renal morphology. Morphometry of the glomerular volume (light microscopy), basement membrane thickness (BMT) and mesangium volume (MV) on electronmicroscopy (EM) were taken according to methods described previously. Results. The animal (anaesthetised) had a mean arterial pressure (MAP) of 104 mm Hg (RR 82 7 mm Hg) at term and PP 88 mm Hg. There was a 200 fold increase in urinary protein excretion from 0.0014 mmol/gCr excreted at 139 days to 0.288 mmol/gCr excreted at term, with a decrease PP to 0.026. There was a decrease in platelet count from 365 X i0/l at 139 days to 245 x 10/l at term. PP the platelet count was 455 X i09/l. There was no other clinical or biochemical evidence of PE. The term biopsy demonstrated the presence of deposits, mesangial expansion and diffuse double-contouring. There were arterial as well as glomerular deposits seen on LM. These changes had resolved on the PP biopsy. A mild interstitial nephritis at the time of the term biopsy resolved. On EM there were fibrin deposits in the term biopsy which had resolved PP. Morphometiy showed that MV and BMT were measurably decreased on the PP biopsy.
Conclusions. Twinning in primates can be associated with renal morphological changes that resemble the changes seen in baboons with uteroplacental ischaemia and in humans with PE. The baboon remains a suitable and available model for studying the pathogenesis of preeclampsia.
ANA, anti-cardiolipin and anti-glomerular basement membrane antibodies in ANCA-associated diseases. Judy Savige, Linus Chant Russell Buchanan, D. Wilson, and D. Davies, University Department of Medicine, Austin Hospital, Box Hill Hospital, VIC and South Western Pathology Service, Liverpool, NSW. A number of autoantibodies have been described in the ANCA-associated diseases. We have looked at the incidence of ANA, anti-cardiolipin (ACL) and anti-glomerular basement membrane (GBM) antibodies in serum from patients with Wegener's granulomatosis (WG), microscopic polyarteritis (MPA), segmental necrotising glomerulonephritis (SNGN) and ANCA-associated vasculitides (VASC ANA were speckled (N = 23), homogeneous (N = 10) or nucleolar (N = 4). There was no correlation between titres of ANCA and ANA, and one antibody could disappear before the other. ANA were found more often in MPA than in WG and were associated significantly more often with pANCA than with cANCA (P < 0.05). Anti-cardiolipin antibodies were also common in the ANCA-associated vasculitides but there was no significant association with any disease type. Finally, anti-GBM antibodies occur in these diseases but are uncommon. ecules termed "advanced glycosylation end products" (AGEp5) which occur in humans with normal aging and at an accelerated rate in diabetes. Their accumulation is thought to be a biochemical link between chronic hyperglycaemia and the pathophysiological complications of diabetes, such as diabetic nephropathy. Glucose is the major circulating sugar and glucose-derived AGEps have been shown to accumulate in subjects with diabetes and/or renal impairment. We have detected abundant deposition of G-6-P derived AGEps immunohistochemically in renal biopsies exhibiting diabetic nephropathy and are therefore seeking to determine the involvement of these compounds in the disease. A competitive ELISA was developed specifically to detect these products utilising antibody against in vitro prepared G-6-P-derived AGE-keyhole limpet haemocyanin. In vitro prepared, G-6-P derived AGE-bovine serum albumin (AGE-BSA), (1 mM AGE-BSA = 11.55 A350) was bound as the solid phase at a concentration of 5 ng/well. Whole blood was collected into heparinized tubes from four groups of subjects: those with diabetes mellitus with and without renal impairment (serum creatinine > 112 ,aMol/l), and nondiabetic patients with and without renal dysfunction. Erythrocytes were haemolysed and delipidated and insoluble material removed. The resulting haemolysate was assayed for AGEp content by competitive ELISA and protein content by the BCA reaction. The average AGE unit/mg protein in the haemolysate of patients who had renal failure was significantly higher (mean = 3.97 2.91, P = 0.0001; and mean = 6.52 9.11, P = 0.0003 for diabetic and non-diabetic patients respectively) than diabetic patients who did not have renal impairment (mean = 0.22 0.13,P = 0.7442) compared to the control group (mean = 0.26 0.16). These data show that glucose-6phosphate derived AGEps accumulate in the circulation of subjects with renal impairment from any cause. Renal deposition of AGEp5 in diabetic patients may be the result of clearance of the increased amounts of AGEps formed during hyperglycaemia, or local formation in situ.
Isolation and characterisation of potentially bioactive advanced glycosylation end products (AGEPs) by lactoferrin (Lt) binding. C.M Brimer, R.P. Mun-ay-Mclntosh, and TJ. Neale, Department of Medicine, Wellington School of Medicine, P0 Box 7343, Wellington South, New Zealand. Circulating and extracellular matrix proteins have been shown to be nonenzymatically glycosylated in vivo and in vitro leading to the formation of AGEPs as brown and/or fluorescent moieties mainly on lysine residues. AGEPs have been implicated in the chronic complications of diabetes by alteration of protein character and in the inflammatory responses which they elicit. We have raised antiserum to in vitro prepared AGEPs and have detected, in patients with renal failure, enhanced binding in haemolysates by ELISA and staining of human diabetic kidney by immunohistochemistry. However only some of the epitopes present in the immunogen may be important in stimulating inflammatory or other responses in cells. The specific cell receptor which binds AGEPs contains a protein with Nterminal sequence identical to that of Lf, and antibody to Lf binds to this Lf-like binding protein. Further, AGEP-albumin binds to immobilised Lf. We have utilised this property of Lf to develop a competitive binding assay for those AGEPs that bind to Lf. A model AGEP, n-acetyl lysine methyl ester (ALME) incubated with glucose-6-phosphate (G6P), competes for Lf in this assay. Competition increased with time of sugar incubation, corresponding with increased brown and fluorescent character, and was greater than with ALME incubated with glucose:
AGEP-Bovine Serum Albumin Equiva
Mean ( A Lf affinity column isolated and allowed further characterisation of potentially bioactive AGEPs from in vitro prepared mixtures. Activity of the column was confirmed by the binding of albumin incubated with G6P but not of control albumin. ALME incubated with G6P was applied and the bound fraction exhibited "brown" character. These Lf-binding AGEPs will be tested for bioactivity, used to study the nature of cellular responses, and to isolate antibodies with specificity for bioactive AGEP moieties in diabetic kidney and other tissues.
The humoral immune response in the lpr mouse. KG.C. Smith, D.M. Tarlinton, and G.J. V Nossal, Walter and Eliza Hall Institute of Medical Research, Post Office Royal Melbourne Hospital, Victoria, 3050. The lpr mouse has a mutation in the fas gene and spontaneously develops an autoimmune disease similar to SLE. Fas is a cell surface molecule which can mediate apoptosis. It is expressed on activated T and B lymphocytes and in germinal centres. An intrinsic B cell defect explains part of the lpr phenotype. These findings suggest a role for fas in the humoral response to antigen. We investigated this by comparing the response to the hapten NP in wild type and lpr C57B1/6 mice. Changes in splenic cellularity after immunisation were similar in both groups. Total anti-NP 1gM and IgG1 and high affinity anti-NP IgG1 rose to the same levels in both groups. NP-specific memory B cells were enumerated using 6 parameter FACS analysis at day 49 after immunisation and the findings confirmed by clonal culture of splenocytes. They made up 0.01% of splenocytes in both groups of mice. Finally somatic hypermutation was studied by sequencing V genes of NP specific cells. In summary splenic involution, affinity maturation of antibody and memory cell generation are all essentially unaffected by the absence of fas. Thus if fas-mediated apoptosis does play a role in humoral responses to antigen it is not critical and other mechanisms can compensate for its absence. Major clinical features were fever (N = 6), night sweats (5), gastrointestinal bleeding (4), proximal myopathy (3) and peripheral neuropathy (3). The serum creatinine at presentation ranged from 0.166 to 0.811 mmol/l. Investigations demonstrated a raised ESR (6), anaemia (6), thrombocytosis (6), hypoalbuminemia (6) and abnormal liver function tests (6). Five out of 5 individuals tested were positive for ANCA (2 cANCA, 2 pANCA and 1 not described). One patient died at admission from gastro-intestinal blood loss but the other 6 were treated with pulse and oral prednisolone, and cyclophosphamide. All 6 remain alive at follow-up after a median of 33 months (range 3 months to 8 years), and all but one have a serum creatinine below 0.2 mmol/l (range 0.106 to 0.209). Polyarteritis overlap syndrome is a not uncommon condition.
Epitope mapping of anti-proteinase 3 and anti-myeloperoxidase antibodies in ANCA-associated diseases. Linus Chang and Judy Savige, University Department of Medicine, Austin Hospital, Heidelberg, Victoria. The protein targets of antibodies may be either linear sequences of amino acids or conformational arrangements. Where the target is a linear sequence, this peptide could be used in a diagnostic assay; in addition any homology with bacterial or viral proteins would suggest that these agents might be important pathogenetically. The aims of this project were to determine whether anti-proteinase 3 and anti-myeloperoxidase antibodies recognise linear epitopes. We have used 3 techniques to look for linear epitopes: polyacrylamide gel electrophoresis (PAGE) under denaturing conditions, enzymatic digestion followed by separation on PAGE or by column chromatography, and an ELISA detection system using overlapping peptides (PIN method). We have shown that anti-proteinase 3 and anti-myeloperoxidase antibodies bind to the corresponding denatured reduced proteins in SDS in Western blots. However these antibodies do not appear to bind to small sequences after digestion with lysC. The antibodies do bind consistently to linear peptide sequences of the corresponding target protein but we have been unable to show that this binding is specific and the binding may reflect some properties of the peptides themselves. We conclude that linear epitopes are uncommon in the major targets of ANCA, proteinase 3 and myeloperoxidase. Previous studies have shown a link between lymphocytic infiltration in the interstitium and deterioration in renal function. We sought to confirm this finding and to further characterise the nature of the T-cells infiltrating the interstitium, based on the subtypes of T-cell antigen receptors (TCR), whether the abundant a TCR or the rarer non MHC linked yb TCR, using reverse transcription (RT) PCR and immunohistochemistry. Thirtysix archival biopsies were obtained from the Royal Adelaide collection: 12 in each group of (a) non immunological renal disease (controls), (b) histologically proven IgAN with stable renal function for at least 12 months and (c) IgAN and progressive deterioration in renal function over at least 12 months. The biopsies had been snap frozen and stored at -70°C for up to 11 years. RNA was extracted, RT to cDNA and amplified using PCR with primers specific for p-actin, the constant gene segment of the alpha (Ca) and delta (Cb) chains. The PCR products were dot blotted onto a nylon membrane and selectively probed with specific 32P labelled probes. All specimens were studied in duplicate and the signal was quantified by two-dimensional densitometry. Results were expressed in arbitrary units as the ratio of TCR to 13-actin signal for each biopsy. Biopsies with a poor densitometry score for 13-actin were not included. Means were compared using the two sample T test. Where sufficient material was available, biopsies were also studied with monoclonal antibodies for CD3, TCRI3 and TCR8 using peroxidase staining. Cellular infiltration was scored by a blinded observer on a four-point scale. Results (means for each group) are shown below: On RT-PCR significant differences were seen between controls and IgAN-progressive for Ca (P < 0.01) and for Cb (P < 0.01). On immunohistology significant differences were seen for both types of T-cell between controls and IgAN-progressive (CD3 P < 0.01, TCRI3 P < 0.001, TCR P < 0.01) and also between IgAN-stable and IgAN-progressive (CD3 P < 0.01, TCR/3 P < 0.01, TCRb P < 0.05). This study confirms the relationship between lymphocytic infiltrate and deterioration in renal function for patients with IgAN. a13 T-cells were increased in both stable and progressive disease. Significant numbers of yb T-cells are only seen in biopsies of progressive IgAN. This new observation has prognostic and therapeutic implications.
Infiltration of the kidney by wf and 'y T-cells: Effect on progression in
Alteration in T lymphocyte function in children with nephrotic syndrome. Stephen Alexander, Kevin Forsyth, and Ian K Hewitt, Renal and Immunology Units, Princess Margaret Hospita4 Perth, Western Australia. To investigate the differences in lymphocyte response to immunosuppression in nephrotic syndrome, we studied suppression of lymphocyte proliferation in children with nephrotic syndrome. Ten patients were studied, 6 in remission off steroids, 3 who were steroid resistant and had required cyclophosphamide and 1 in relapse. There were 6 boys and 4 girls (ages 22 months-14 years 10 months). There were 10 controls in hospital for minor surgery. Five were boys and 5 girls (ages 27 months-13 years 5 months). Ten mis of blood was separated using ficoll-hypaque then washed with RPM! counted and suspended in RPM! with 10% FCS and 1% pyruvate, glutamine and non essential amino-acids. io cells were suspended in each well of a 96 well tray. Lymphocytes were cocultured with either PHA or anti-CD3 as mitogens and then either prednisolone or cyclosporin A were added in varying concentrations. The lymphocytes were incubated for 48 hours and pulsed for 18 hours with tritiated thymidine. Cells were harvested on a titretrek analysed on a scintilator and results expressed as a proportion of maximal response. Lymphocytes were also analysed using flow cytometry to study a range of subclass and activation markers. The lymphocytes showed a trend of delayed suppression in those stimulated by PHA but not in those stimulated by anti-CD3. There were no significant differences in the cell surface markers examined by flow cytometry. In most patients, the inheritance of Alport's syndrome is X-linked and in about 10% of these a mutation has been demonstrated in the alpha 5 chain of type IV collagen. We report here our results in a study of 9 affected families. DNA was extracted from peripheral blood leucocytes, cut with the restriction enzymes EcoRI, PstI and TaqI, electrophoresed, blotted and probed. The eDNA probes were derived from polymerase chain reaction (PCR) amplification of normal human mRNA using primers from the published sequence of the alpha 5 chain of type IV collagen. No novel alleles were demonstrated indicating that there were no large deletions nor sequence substitutions that altered the restriction enzyme recognition sites in any of these families. We suspected that autosomal recessive inheritance was implicated in one of these families and examined the DNA with eDNA probes from the alpha 3 and 4 chains of type IV collagen. Again however we found no mutations. We conclude that the majority of mutations in Alport's syndrome are single base pair substitutions, and some may affect a novel type IV collagen chain and non-coding regions of the gene. Finally we have shown that mRNA corresponding to the alpha 5 chain is present in both skin and bone marrow and these tissues can be used to look for single base pair substitutions using PCR and direct sequencing.
Detection of mutations in
Assessment of adequate dialysis delivery in continuous ambulatory peritoneal dialysis (CAPO). L.H. Fung, C.A. Pollock, L.S. Ibels, Ri.
Caterson, D.A. Waugh, C. Macadam, and IF. Mahony, Department of Renal Medicine, Royal North Shore Hospital, St Leonards, 2065, Australia. Although adequate dialysis and its parameters are reasonably well established in conventional haemodialysis, its assessment in CAPD is as yet ill defined. The present study was designed to assess the relevance of urea kinetic modelling and the peritoneal equilibration test (PET) in CAPD in relation to nutritional markers and overall morbidity. Twenty-four hours dialysate and urine collections were made in 25 patients (13 M, 12 F; age 21-77 years) on CAPD for 15.2 2.9 months, from which the Kt/V, protein catabolic rate (PCR), urea and creatinine clearances were determined. The following day patients underwent a standard four hours PET at which time serum albumin, cholesterol, triglycerides and total protein were also measured. Data regarding total body nitrogen (TBN) measurement within the preceding 6 months, hospital admissions and infectious complications within the last 12 months were reviewed. The study demonstrated that total KtIV delivered was highly dependent on residual renal function (P < 0.0001), and KtIV derived from peritoneal clearance diminished with increasing age (P < 0.01). However, a higher delivered total Kt/V was associated with increased PCR (P < 0.05), which in turn was associated with an improved TBN (P < 0.05). The TBN further correlated with peritoneal glucose absorption (P < 0.005). Hospital admission rate decreased with improved PCR, although it failed to reach statistical significance (P = 0.067). Infectious complications further correlated with time on dialysis (P < 0.005) and with dialysis protein loss (P < 0.05), but not with serum albumin (P = 0.31). Although KtIV determinations did not correlate with clearances determined by the PET, the dialysate/plasma creatinine ratio (DIP Cr) did correlate with PCR (P <0.05) and with TBN (P < 0.001) but not with infectious complications nor hospitalization. The D/P Cr further correlated with peritoneal glucose absorption (P < 0.0005) and inversely correlated with ultra-filtration rate (P < 0.05). In general, serum albumin did not correlate with morbidity, nor other markers of dialysis adequacy. However, in female patients the rate of hospital admissions decreased with improved albumin level (P < 0.05). In conclusion, nutritional parameters of TBN and PCR correlate with outcome on CAPD. An integral relationship exists between nutritional status and dialysis delivery, which is best assessed by urea kinetic modelling. Although D/P Cr is a reasonable marker of nutritional status in CAPD patients, its value in assessing the adequacy of dialysis delivery is yet to be determined.
Total body nitrogen (TBN) as a prognostic marker in maintenance dialysis. CA. Pollock, L.S. Ibels, B.J. Allen, W. Ayass, R.J. Caterson, D.A. Waugh, C. Macadam, Y. Pennock, and J,F. Mahony, Department of Renal Medicine, Royal North Shore Hospital, NSW 2065. It is increasingly appreciated that adequate dialysis is reflected in an adequate nutritional state and both are necessary to achieve an ultimately good prognosis. In order to assess long term nutritional adequacy, 151 patients (77 M, 74 F), aged 55.3 1.3 yrs on maintenance dialysis (73 HD, 78 CAPD), underwent measurement of TBN by neutron activation analysis. Dietary history, anthropometrics and serum albumin were also measured. Sixtyeight patients were reassessed 22.6 2.1 (6-72) months later. In cross sectional analyses anthropometric measurements and dietary intake remained stable over time in all patients. However, a significant fall in TBN occurred in the HD population with increasing time on dialysis (P < 0.05).
In the prospective analyses, the fall in TBN in HD patients (N 36), expressed as a % of normal nitrogen in the matched population (Nitrogen Index), did not reach significance (87.6 0.2 vs. 85.3 1.8%; P = 0.16), but in the CAPD patients (N = 25) a significant increase in TBN occurred (89.2 3.3 vs. 95.2 3.1%; P <0.05). tn 7 patients who transferred from CAPD to HD a fall in TBN was evident 96.6 7.2 vs. 85.3 2.2%; P < 0.05). TBN correlated with total caloric intake estimated from the dietary history (P < 0.05), but not with estimated protein intake. During follow up 38 patients died. These patients were older (P < 0.05). In the APD population they had been on dialysis for a greater length of time (34.3 5.3 vs. 15.5 2.6 months; P < 0.05), although this was not the case in the HD patients. In all dialysis patients, those who died had a lower TBN expressed both as g/kg lean body mass (31.0 0.6 vs. 33.5 0.4; P < 0.005) and as the nitrogen index (87.2 2.1 vs. 92.8 1.4%; P < 0.05).
A lower serum albumin was associated with mortality in the APD patients (35.8 0.6 vs. 31.6 3.8 g/dl; P < 0.05), but this relationship was not observed in the FID subpopulation. Anthropometric measurements and dietary history were similar in those who died compared with survivors. We conclude that CAPD exerts a favourable influence on TBN and that anabolism is possible. No such effect was observed in the HD patients. In both populations TBN is inversely associated with increased mortality which is not predictable from measurements of anthropometry or serum albumin. Total caloric intake determined by dietary history is a better index of nutritional adequacy than is estimated protein intake.
Accuracy, patient tolerance and time-efliciency of volumetric versus manual ultrafiltration (UF) on haemodialysis (HD). D. Perreit, S. Porter, F.S.D. Ken, A. Parnham, Incentre Dialysis Staff G. Thatcher, P. Hurst, and M Thomas, Dept. of Nephrology, Royal Perth Hospital, WA 6001. To determine whether the added cost of volumetric UF devices affects the accuracy, tolerance or nurse-time efficiency of maintenance HD, a crossover comparison with manual UF (via calculated trans-membrane pressure) was performed in 12 patients with recurrent hypotension on Incentre hospital HD. The mean absolute difference between the desired and actual post-dialysis body weight, the incidence of hypotension (fall in systolic BP > 25 mm Hg or need for saline), visual analogue symptom (VAS) scores (nausea, headache, cramp, itch and well-being) and stopwatch-recorded nurse UF calculation times were studied for 3 dialyses on each form of UF on 2 consecutive weeks. All patients used cuprophane membranes, Cobe Centry 2 HD machines, bicarbonate dialysate, with no change in dialysis prescription, dialysis nurse or clinical status during the study period. The sample size was selected to detect a difference in desired versus actual post-dialysis weight of 0.3 kg between the 2 forms of UF with 90% power at .01 level of significance. Data was expressed either as mean (Sn) and categorically (improved, unchanged, worsened) and analysed by one-way ANOVA and Chi-square test. All patients completed the study. There were no significant differences between volumetric and manual UF in any parameter either pre-HD (not shown) or post-HD (Table), including nausea, headache and itch (not shown).
Systolic

UF Mode
Weight diff This study shows no justification for the use of volumetric UF in maintenance HD using cuprophane membranes. In Uraemia the complex requirements/restrictions make adherence to NHF lipid lowering dietary guidelines and patient compliance difficult. Also there is no data to support benefit of such manipulation. We have conducted a 14 week study of dietary control, in dialysis patients, limiting total fat intake to 30% (PD) and 40% (HD) of total calories with as close a 1:1:1 poly:mono:saturated fat ratio as possible. Results: Further data will be presented. Current dialysis diets are close to optimum. Further manipulation according to NHF lipid lowering recommendations may be deleterious. Treatment of uraemic dyslipidaemia is likely to require pharmacological therapy.
A new, non-invasive method of measuring blood volume (By) during haemodialysis using optical techniques. D. W. Johnson, M.P. McMahon, S.B. Campbell, and S.J. Fleming Department of Renal Medicine, Royal Brisbane Hospital, Qld, 4029. To aid in the clinical assessment of patient hydration state, we developed an inexpensive method of measuring BV during haemodialysis, based on the linear relationship between BV and haemoglobin concentration ([Hb] ) and between Hb] and near-infrared light absorption by blood. An optical monitor and light source were clamped across transparent blood lines in 10 haemodialysis patients in order to provide a continuous recording of [Hb] . In each patient, a strong linear correlation was found between received optical power and [HbI concentration (r 0.975). By analysing the rates of change of [I-IbJ, and therefore of By, at two different rates of fluid removal and solving 2 simultaneous equations, BV was determined in 10 patients and compared with the concomitant BV measured by the standard technique of radioisotope dilution. Using linear regression, a statistically significant, strong correlation was found between the two methods (P 0.004, r = 0.822, y = 3.707 + 0.225x). The overall accuracies of the spectrophotometricallyderived BV measurements were of the order of 400 ml. The advantages of the technique included its simplicity, low cost, rapidity, repeatability, safety and portability. In conclusion, we found that this practical new technique could accurately measure BV during a haemodialysis session, thus providing a useful adjunct to the clinical assessment of hydration state. new Australian formulation CA was compared to CC in a 24 week randomised, blinded, cross-over study in 31 maintenance haemodialysis (lID) patients, aged 51 24 (an) yrs. Data up until the time of crossover (12 weeks) are available. During and following an initial run-in period of 4 weeks 14 patients received CA first, and 17 patients CC. Mylanta was added when serum phosphate was > 1.80 mmol/L with maximum tolerated dose of CA or CC. Prior to crossover, serum calcium was 2.37 0.15 (CA) and 2.46 0.21 (CC) mmol/L, P = NS. Serum phosphate was 1.36 0.21 (CA) and 1.52 0.21 (CC) mmol/L, P = NS. There were 2 episodes of hypercalcaemia ( 2.70 mmol/L) in 1 patient with CA, and 5 episodes in 2 with CC. Serum phosphate was 2.00 mmol/L on 2 occasions in 2 patients on CA, and on 5 occasions in 2 on CC. CA dose at crossover was 2000 912 mg Ca2 day, and CC dose 2356 2072 mg Ca2/day. Although mean Mylanta dose was similar in the both groups 14.1 mg/24 hrs mean SD normal 6.3 3.2 mg/24 hr) together with T cell (1.0 0.06 cells/glom cross section c/gcs; normal 0.1 0.02 c/gcs) and macrophage (4.2 0.26 c/gcs; normal 0.1 0.1 c/gcs) infiltration. Dermal rechallenge results in skin swelling (sheep globulin response 3.1 0.7 mm; horse globulin response 3.1 0.7 mm (P < 0.05). Rats given anti-P selectin antibody had significantly less proteinuria (13.8 7.3 mg/24 hrs) as well as glomerular T cell (0.3 0.06 c/gcs) and macrophage influx (0.7 0.13 c/gcs) all P < 0.05. Dermal skin response to sheep globulin rechallenge was significantly reduced to control levels (1.8 0.1 mm P < 0.05). These results suggest that the primary effector response in dermal and glomerular DTH is P selectin dependent T cell recruitment. Victoria 3050 Australia. Objective: Clusterin (rat sulphated glycoprotein-2) has been isolated from several tissues including the kidney and is thought 943 to be induced during tissue damage. We have examined the expression of the clusterin gene in the kidney during the development of cyclosporine A (CyA) induced nephrotoxicity in the rat using in situ hybridization histochemistiy. Design and Methods: Female Sprague Dawley rats (170 g) were divided into experimental or control groups and were given intraperitoneal injections of CyA (25 mg/kg) or vehicle respectively for 2, 4, and 6 weeks. Kidneys from animals sacrificed at these times were fixed in 4% paraformaldehyde and embedded in paraffin. Tissue sections were hybridized using either a sense or antisense riboprobe of 1100 bases complementary to clusterin mRNA which was labelled with P32. Results: Clusterin gene expression was not detected in control animals. Expression of clusterin in distal convoluted tubules of CyA treated animals was evident at 2 weeks and increased substantially at 4 weeks and 6 weeks. The increase in clusterin positive tubules was associated with progression of tubulointerstitial nephritis. At 6 weeks clusterin expression was also seen in afferent arterioles, the glomerular capsule and transitional epithelium of the renal pelvis of CyA treated rat kidneys. No specific labelling was seen at any time with the sense probe. Conclusions: CyA nephrotoxicity is associated with a progressive increase in clusterin gene expression in tubules and arterioles, which precedes histopathological lesions and may be a marker of cell injury.
Clusterin expression in experimental cyclosporine
